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ABSTRACT 
 
Escherichia coli O157:H7 is a human pathogen that causes food-born infections with 
symptoms that range from mild diarrhea to hemorrhagic colitis, and in a small percentage of 
patients, hemolytic uremic syndrome (HUS). Although tissue adherence is a critical factor in 
its pathogenicity, it has not been completely defined. The formation of biofilms is a 
mechanism that confers bacteria several advantages when growing under less favorable 
conditions. Biofilm development, structure, and regulation on abiotic surfaces have been 
extensively studied for E. coli O157:H7, but its role during pathogenesis or colonization of 
hosts still remains to be fully understood, mainly because most strains have not been shown 
to produce biofilms under normal laboratory culture conditions. However, an important 
linkage between biofilm formation and cellular adherence in E. coli O157:H7 strain EDL933 
has been established. In this study we investigated the extent to which biofilm formation 
contributes to adherence in strains Sakai and 86-24 that lack in vitro biofilm forming 
activities. We determined that these poor biofilm forming strains are induced to produce 
biofilms in vitro under growth limiting conditions. We also deleted 6 genes in both strains 
related to biofilm formation in strain EDL933 (aroC, ecpD, hlyD, csgA, relA and yaiH). A 
significant reduction in adherence to HEp2 and T84 cells was demonstrated for all of the 
biofilm gene negative mutants, providing evidence that biofilm related genes found in 
EDL933 are also essential for cell adherence in Sakai and 86-24. Biofilm induced strains also 
adhered better to the epithelial cells. Finally, a microarray analysis showed that Sakai up-
regulates curli associated genes in the presence of cultured epithelial cells. These studies 
show that the adherence of E. coli O157:H7 to epithelial cells is strongly linked to biofilm 
formation, and that at least the initial steps in biofilm formation play important roles in the 
cellular adherence of E. coli O157:H7. This linkage might be further explored to understand 
how biofilm production at the mucosal epithelium interface contributes to high persistence 
and intermittent shedding in cattle and plays a role in the cellular adherence to human 
intestines and contribute to its pathogenicity there.
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
Escherichia coli O157:H7 is a human pathogenic bacterium that causes food-born 
infections with symptoms that range from mild diarrhea to hemorrhagic colitis. Most patients 
recover from the infection within the first 10 days, but in a small percentage of patients (up to 
10%), particularly young children and the elderly, the infection may lead to hemolytic uremic 
syndrome (HUS). HUS is characterized by acute renal failure, hemolytic anemia and 
thrombocytopenia. It can also cause neurological complications in a quarter of the patients 
and chronic renal disease in around half of the survivors. The case-fatality rate ranges from 
3% to 5% (250).  
Many virulence factors have been identified for this pathogen. This includes a 
pathogenicity island known as locus of enterocyte effacement (LEE) that contains all of the 
essential genes that cause attaching-effacing (A/E) lesions on intestinal epithelial surfaces 
through activation of a Type III secretion system (100). The A/E lesion is characterized by 
the loss of microvilli and accumulation of cytoskeletal components to form a pedestal on the 
host cell upon which the bacteria rests (69). The adhesin encoded by eae on the LEE is a 
surface protein called intimin that facilitates the intimate binding to the host intestinal cell by 
binding to the bacteria-encoded receptor Tir that is translocated into the eukaryotic cell and 
positioned on the cell surface (102). Once the adherence of bacteria to the bowel mucosa is 
established, the bacteria will secrete extracellular shiga-like cytotoxins (161) or 
verocytotoxin (VT) that contributes to an intense inflammatory response and damage to the 
epithelium.  
Tissue adherence is a critical factor in its pathogenicity because it is the originating 
incident that determines its pathogenic potential. Adherence, however, has not been 
completely defined, mainly because of the numerous potential fimbrial operons and other 
factors that alter the host cell physiology (104). Biofilm formation is increasingly being 
recognized as a significant contributor to disease in other bacterial species (173), but its 
linkage to pathogenesis in E. coli O157:H7 has not been well documented mainly because 
most strains have not been shown to produce biofilms under normal laboratory culture 
conditions (54, 130, 132). Nonetheless, recent studies have shown that unlike wild type cells, 
biofilm-negative mutants adhere poorly or not at all to Hep2 and T84 epithelial cells 
establishing an important linkage between biofilm formation and cellular adherence in E. coli 
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O157:H7 strain EDL933, a strong in vitro biofilm-producing strain (187, 188). While these 
studies support a critical role of biofilm activity in adherence in strain EDL933, it is still 
necessary to directly show that biofilm formation contributes to adherence in other strains, 
especially those lacking in vitro biofilm forming activities. In order to investigate the extent 
to which biofilm formation contributes to adherence in strains Sakai and 86-24, three specific 
aims were followed: 1) Determine if non-biofilm forming strains (Sakai and 86-24) can be 
induced to produce biofilms in vitro. 2) Determine if biofilm related genes found in EDL933 
are essential for cell adherence in Sakai and 86-24 strains. 3) Determine the transcriptional 
differences in a non-biofilm forming strain in the presence and absence of epithelial cells. 
These objectives aim to prove the working hypothesis for this thesis that the adherence of E. 
coli O157:H7 to epithelial cells requires the initiation of biofilm formation. The linkage 
between biofilm formation and adherence of E. coli O157:H7 could be used to understand 
how biofilm production in this pathogen at the mucosal epithelium interface contributes to its 
high persistence and intermittent shedding in the cattle as well as playing a role in the cellular 
adherence to human intestines and contribute to its pathogenicity. 
Thesis Organization 
This thesis is written in a modified alternate format to meet the Interdepartmental 
Genetics Program requirements. It begins with a Literature Review (Chapter 2) starting with 
a general discussion of E. coli pathogens followed by a discussion of serotype O157:H7 
pathogenesis. Next in Chapter 2 is a general discussion of biofilms with an ending section on 
biofilms of serotype O157:H7 and references. Chapter 3 is in manuscript format for Infection 
and Immunity. As such it includes an Abstract, Introduction, Materials and Methods, Results, 
and Discussion with References at the end of the chapter. Chapter 4 describes the 
recommendations for future research. Appendices A, B and C follow and the thesis closes 
with Acknowledgements. All work described in this thesis was performed by M. Stephenson. 
Summary with Goals and Hypothesis 
The overall goal of this research was to determine if E. coli O157:H7 strains that produce 
little to no biofilms in the laboratory (Sakai and 86-24) are dependent on biofilm forming 
activites for attachment to human epithelial cells. Additionally, we hoped to gain insights 
into the process by which biofilms are controlled in these strains.  
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CHAPTER 2. LITERATURE REVIEW 
Escherichia coli Pathogens 
Escherichia coli is a gram negative, facultative anaerobic and non-sporulating rod-shaped 
bacterium first discovered in 1885 by Theodor Escherich (63). Classified into the 
Enterobacteriaceae family of gamma-proteobacteria (158), it is commonly a commensal 
bacterium normally found in the gut flora of endotherms. Most strains are harmless 
commensals (13, 94, 193), but some serotypes can cause disease (33, 243). 
Escherichia coli include a great population of phenotypically and genetically higly 
variable organisms, with only about 20% of the genome shared between all strains (133). A 
strain of E. coli is a sub-type or genetic variant within the species that has distinctive 
characteristics that differentiate it from other E. coli strains. Another subdivision 
classification scheme of E. coli that does not use evolutionary relatedness is serotype, which 
is based on major surface antigens according to the Kauffman scheme (O:somatic; 
H:flagellar; K:capsular) (169). 
Certain strains of E. coli have acquired virulence traits through normal biological 
processes and have become pathogenic to humans and animals. The infection with these 
pathotypes can cause gasteroenteritis and extraintestinal infections such as urinary tract 
infections, sepsis and meningitis. The most commun extraintestinal infection is the urinary 
tract infections that are caused by uropathogenic E. coli (UPEC). The pathotype responsible 
for meningitis and sepsis is the meningitis-associated E. coli (MNEC) (104). All of the 
extraintestinal pathotypes have recently been refered to as ExPec (202). The enteric 
pathogens have been further categorized as enteropathogenic E. coli (EPEC), 
enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. 
coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC) (156). 
Enterotoxigenic E. coli causes watery diarrhea and is responsible for the majority of cases 
of infantile diarrhea in the developing world as well as ‘traveler`s diarrhea’. Annually it 
causes more than 200 million cases of diarrhea killing approximately 380,000 people, many 
of which are children (249). Although it does not invade, it binds enterocyte cells through its 
fimbrial adhesins. It also produces two enterotoxins: a heat-stable (ST) enterotoxin toxin that 
causes cGMP to accumulate and the host cells to secrete fluid and electrolytes into the 
intestinal lumen and a heat-labile (LT) toxin similar to the cholera toxin (220).  
Enteropathogenic E. coli also causes diarrhea especially in children of the developing 
world. Contrary to ETEC, EPEC lack ST and LT toxins, but they bind to host intestinal cells 
through an adhesin known as intimin and possibly through a type IV pilus (79), a rod-like 
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fimbriae and fibrillae (78). When it adheres to the intestinal mucosa it provokes host cells to 
rearrange its actin creating attaching and effacing (A/E) lesions (37). Additional EPEC 
virulence factors include a lymphostatin (LifA) that inhibits lympohocyte activation (115). 
Diarrhea is probably the result of multiple factors that include active ion secretion, increased 
permeability, lack of reabsorptive capacity of the colon, and inflammation (104). 
Enteroaggregative E. coli (EAEC) attach to tissue culture cells in an aggregative manner. 
These strains are associated with persistent mucoid diarrhea in young children. The 
pathogenesis of EAEC is not well understood, however they do produce some cytotoxic 
effects (155). They adhere to the intestinal mucosa where they form characteristic biofilms 
and cause non-bloody diarrhea and inflammation (246). The biofilm formation is thought to 
be involved with its persistent diarrhea.  
Enteroinvasive E. coli closely resembles Shigella biochemically, genetically and 
pathogenically. Enteroinvasive E. coli may cause an invasive colititis that causes 
inflammation resulting in dysentery, but mostly it penetrates the cell wall of the epithelial 
cells in the colon in which it intracellulary multiplies, causing cell destruction and extreme 
watery diarrhea. Enteroinvasive E. coli might produce enterotoxins that could be involved in 
the production of the watery diarrhea (156). 
Diffusely adherent E. coli (DAEC) are characterized by a diffuse adherence to HEp-2 or 
HeLa cells in-vitro. DAEC have been associated to diarrhea in children. It produces a 
fimbrial adhesins (15) that might induce functional injuries that promote injuries in the brush 
border of the cells (176). 
Enterohaemorrhagic E. coli (EHEC) is a subgroup of the E. coli called vero-toxin E. coli 
(VTEC) or Shiga-like toxin E. coli (STEC). It causes abdominal cramps, bloody diarrhea, 
and non-bloody diarrhea. Fever and vomiting can also occur. The incubation period has a 
median time of three to four days, but it can range from three to eight days. Most patients 
recover from the infection within the first 10 days, but in a small percentage of patients (up to 
10%), particularly young children and the elderly, the infection may lead to hemolytic uremic 
syndrome (HUS). This sequale is characterized by acute renal failure, hemolytic anemia and 
thrombocytopenia. It can also cause neurological complications in a quarter of the patients 
and chronic renal disease in around half of the survivors. The case-fatality rate ranges from 
3% to 5% (250). Other complications include central nervous system deterioration, blindness, 
partial paralysis, thrombotic thrombocytopenic purpura, diabetes, intussusception, colonic 
perforation with peritonitis and sepsis, rectal prolapse, pancreatitis, hemiplegia, and seizures 
(21). The major virulence factor of EHEC is its Shiga-like toxin (Stx) or verocytotoxin (VT). 
The toxins contribute to an intense inflammatory response and damage to the epithelium. 
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EHEC attaches using a type III secretion system and intimin adhesion producing A/E lesions 
like EPEC. Enterohaemorrhagic E. coli also produces non-Stx molecules such as cytolethal 
distending toxin which can also cause endothelial and vascular injury (106). Although 
multiple serotypes of EHEC are known, the most known and important of the EHEC strains 
in relation to public health in the U.S. is E. coli O157:H7 (147). 
Escherichia coli O157:H7 
Escherichia coli O157:H7 was first recognized as a pathogen in 1983 when it was 
identified as the cause of a 1982 outbreak of gastrointestinal disease. The origin was traced to 
contaminated ground beef in hamburgers from Jack in the Box in Oregon and Michigan 
(196). In this first outbreak four children died and approximately 700 people became sick. 
Since then it has been implicated in sporadic outbreaks of food-borne illness around the 
world, including the United States (191), Europe (55, 57, 101, 138), Japan (150) and 
Australia (120) (Table 1). The data on the situation in developing countries is limited, mainly 
because it is not routinely monitored (250). The incidence is highest during warmer months. 
About 88 percent of all outbreak cases have occurred between May and November.  
Escherichia coli O157:H7 is a major economic burden not only because of the cost of the 
disease but also in terms of food recalls and legal proceedings. The CDC estimates 73,480 
cases annually leading to 2,168 hospitalizations, 60 deaths and an economic cost of $405 
million (in 2003 dollars), including $370 million for premature deaths, $30 million for 
medical care, and $5 million in lost productivity (71). For 2010, an estimated cost of 
$488,771,183 was calculated as the cost of illness (239). Although all EHEC can cause HUS, 
several studies have made known that infection with E. coli O157:H7 is responsible for most 
cases of HUS in the U.S. (16, 17, 107, 155). Table 1 lists the major outbreaks of E. coli 
O157:H7 in the world.  
Reservoirs and sources 
Animal reservoirs include cattle, sheep, goats, and others.  
Cattle. Cattle are considered the primary reservoir for E. coli O157:H7 and the most 
common source for food-borne infections (90, 259). It is not pathogenic to mature cattle, but 
individual animals can passively shed E. coli O157:H7 in their feces for several days without 
establishing a colonized state, or can pass fecal E. coli O157:H7 for a longer time if the 
bacteria colonize and persist (83). Evidence indicates that the recto-anal junction (RAJ) 
mucosa is one of the primary sites of E. coli O157:H7 colonization in cattle (157). Reported 
incidence among cattle varies; the results of two major U.S. studies indicated that 31 (3.2%) 
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of 965 dairy calves (259) and 191 (1.6%) of 11,881 feedlot cattle were positive for E. coli 
O157:H7. An additional 0.4% of feedlot cattle were positive for E. coli O157:H7. E. coli 
O157:H7 levels in calf feces range from <102 CFU/g to 105 CFU/g (259). More than one 
strain of E. coli O157:H7 can be isolated from the feces of the same animal or different 
animals within the same herd (149). 
 
Table 1. Significant outbreaks of E. coli O157:H7*. 
Year Location 
1984  Osaka and Tokyo, Japan. 
1990  Urawa Kindergarten water well in Saitama, Japan. 
1996 Unpasteurized apple juice from Odwalla. 
1996  Radish sprouts in Sakai, Osaka, Japan. 
1996 School lunch in Okinawa, Japan. 
1997 Ground beef from Hudson Foods Company of Rogers, Arkansas. 
1999 Drinking water at the Washington County Fair in Easton, New York.  
2000 The suspected contaminant was a Wendy´s restaurant but the link was 
never conclusively proven. 
2000 Meat from Excel meat packing plant, Colorado. Outbreak in 
Milwaukee, Wisconsin.  
2002 Ground beef from ConAgra plant in Greely, Colorado.  
2005 Marinade products in public nursing home in Kagawa, Japan. 
2005 Schools in South Wales, U.K (205). 
2006 Taco Bell in South Plainfield, New Jersey and Long Island.  
2006 Bagged spinach by Natural Selection Foods supplied by Earthbound 
Farm in San Juan Bautista. Outbreak across 25 US States. 
2007 Beef packed by United Food Group.  
2007 Ground beef from the Topps Meat Company in Elizabeth, New Jersey 
2007 Food from school cafeteria Tokyo, Japan. 
2008 Sausage and ham in Canada and USA. 
2009 Nestle Toll House refrigerated cookie dough. 
2010 Thought to be beef in 16 different U.S states. 
2010 Bravo farms cheese in five U.S states.  
2011  In-shell walnuts in Michigan, Minnesota and Wisconsin. 
* (33) 
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Sheep. Sheep have also been identified as a reservoir of E. coli O157:H7 (119). As with 
cattle, it causes no disease and is considered commensal. 
Others. Several studies showed that E. coli O157:H7 can also be carried by deer, horses, 
pigs, goats, dogs, wild birds, rabbits, ducks and flies (35, 110, 128). Environmental studies 
have determined that E. coli O157:H7 can persist in soil, manure, water, and other places on 
farms, including implements (35, 90). It can be introduced into food crops through 
contaminated animal derived fertilizer or polluted irrigation water (70, 222) and then persists 
in raw and undercooked foods (52, 95), food processing surfaces (252), and households 
(142). There is also one report indicating potential airborne transmission after exposure to a 
contaminated building (240).  
Transmission 
Most of the outbreaks have occurred through the consumption of contaminated food, 
primarily products derived from cattle or their products including manure contamination 
(84). This is related to the fact that E. coli O157:H7 is present in the intestines of healthy 
cattle and cattle products may get contaminated during slaughter. Ground beef is particularly 
susceptible because the grinding process may transfer pathogens from the surface of the meat 
to the interior. Also, ground beef usually contains meat from many animals, and a small 
number of infected animals can contaminate a large supply of ground beef. The fact that the 
meat is sometimes incompletely cooked also plays a role since bacteria can survive and be 
consumed (21).  
Infection has also occurred from other sources such as vegetables. For example, the 
largest reported E. coli O157:H7 outbreak, the Japan outbreak in 1996, was associated with 
radish sprouts (151). Drinking water, (230) swimming water (109), and pasteurized apple 
juice and cider (14) have also been found as sources. Secondary person to person infection 
can also occur (224) as a result of the low infectious dose reported to be from 2 to 2000 cells 
(26). This type of transmission can occur predominantly in day care centers (12) and nursing 
homes (32). Dry-cured salami was associated with an E. coli O157:H7 outbreak in the 
western United States, indicating that the bacteria can survive in acidic, fermented meats 
causing illness when consumed (235). The source of the infection is often not identified, but 
links have often been made with the intake of food in restaurants (247). 
Genome sequence  
The genome sequence of E. coli O157:H7 strain EDL933 revealed a chromosome of 5.5 
megabases in length encoding 5416 genes. It had a chromosome approximately 850 kb larger 
 8 
when compared to the common lab strain E. coli K12 MG1655 (178). The pathogenic 
serotype O157:H7 and the laboratory strain K12 MG1655 shared a common ancestor thought 
to exist about 4.5 million years ago (194). Both strains share a common backbone of 4.1 
megabases with a similar gene order and 75,168 single nucleotide polymorphisms. It is co-
linear except for one 422-kilobase (kb) inversion spanning the replication terminus. The 
regions that are unique to the E. coli O157:H7 genome are O-islands that total 1.34 
megabases of DNA. Roughly 26% of the EDL933 genes (1,387/5,416) lie entirely within O-
islands. Of the O-island genes, 40% (561) can be assigned a function. The regions unique to 
K12 are K islands that total 0.53 megabases. The lineage-specific segments are found 
throughout both genomes in groups of up to 88 kb. There are 177 O-islands and 234 K-
islands greater than 50 bp in length. Another 338 EDL933 genes marked as unknowns lie 
within phage-related clusters and are probably remnants of phage genomes. About 33% 
(59/177) of the O-islands contain only genes of unknown function. Many classifiable 
proteins are related to known virulence-associated proteins from other E. coli strains or 
related enterobacteria. Within the backbone there are 3,574 protein-coding genes with an 
average nucleotide identity between O157 and K12 of 98.5%. Eighty nine percent of the 
orthologous genes are of equal length and only 25% encode identical proteins (178).  
Virulence factors 
Nine large O-islands (0.15 kb) encode putative virulence factors: a macrophage toxin and 
ClpB-like chaperone; a RTX-toxinlike exoprotein and transport system; two urease gene 
clusters; an adhesin and polyketide or fatty-acid biosynthesis system; a type III secretion 
system; two shiga toxins and a PagC-like virulence factor; a fatty-acid biosynthesis system; 
and the described locus of enterocyte effacement. Other smaller islands that may be involved 
in virulence contain fimbrial biosynthesis systems, iron uptake and utilization clusters, and 
putative non-fimbrial adhesins. Many clusters have no obvious role in virulence, but may 
confer strain-specific abilities to survive in different niches (178).  
A large plasmid called pO157 of 92 kb is found in most EHEC O157:H7 strains. Its role 
in pathogenicity is not clearly defined (104), but it has been correlated with virulence in some 
studies. Eighty-seven percent of the sequence encodes one hundred open reading frames 
(ORFs) (27). Twenty of these ORFs encode virulence factors including the four genes of the 
hemolysin locus (209), a catalase peroxidase (25), an extracellular serine protease (24), 13 
genes comprising a type II secretory system (210), cytotoxin (27), one potential adhesin 
(ToxB) (232) and the StcE protein. StcE cleaves the C1 esterase inhibitor (C1-INH) of the 
complement pathway and could potentially contribute to tissue damage, intestinal edema and 
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thrombotic abnormalities that are seen in EHEC infections (125). The genes for the 
enterohemolysin locus (Ehx) are organized in an operon in the order ehxCABD (211). The 
role of Ehx in pathogenesis is not completely defined, but there is a strong association 
between production of Stx and Ehx. Also, it has been shown that EhxA is reactive to sera 
from HUS patients (209), and ehxD has been linked to biofilm formation (187) The 
extracellular serine protease called EspP is an autotransporter that has proteolytic activity 
against pepsin A and the human coagulation factor V. The cleavage of factor V in bowel 
mucosa can be a contributor to the hemorrhage in the gastrointestinal tract (24). The 
catalase/peroxidase is mainly located in the periplasm helping the bacteria to escape host 
responses, it also participates in the recovery of the bacteria from heat stress (25). 
In order to cause infection, the organism must pass through the acidic environment of the 
stomach, and there are several mechanisms that enable it to resist these conditions: an acid-
induced oxidative system, an acid-induced arginine-dependent system, and a glutamate-
dependent system (126). Once in the gut, E. coli O157:H7 forms attaching and effacing 
(A/E) lesions on the infected human intestinal epithelial cells (161, 174). In cattle, the ability 
of the organism to colonize the intestine appears to also require attachment to intestinal 
epithelial cells with induction of A/E lesions (157). A/E lesions are characterized by the loss 
of microvilli (effacement) and the induction of a pedestal of polymerized actin and other 
cytoskeletal elements that forms underneath and around the infecting bacterium (69). All the 
necessary genes to produce the A/E lesions are encoded in the chromosomal pathogenicity 
island termed the locus of enterocyte effacement (LEE) (144, 145). The LEE can be divided 
into 5 distinct operons: LEE1, LEE2, LEE3, LEE4 and LEE 5 (153) and encodes for a 
regulator Ler, structural components of the Type III Secretion System (TTSS), secretory 
proteins, adhesins, translocators and effector proteins (177). At one end of LEE are the genes 
espA, espB and espD encoding secreted proteins required for signal transduction and A/E 
activity. At the other end, lie the genes for the TTSS sec and esp. A region between the two 
contains the eae gene encoding intimin, a surface protein required for intimate attachment 
and tir encoding the protein Tir, which acts as a receptor for intimin (60). Since the presence 
of LEE is strongly associated with particular VTEC lineages, the intimin gene and the entire 
LEE can be spread horizontally although it is a rare event (18). Regulation of LEE gene 
expression is complex, and depends on environmental conditions, quorum sensing, and 
several regulators, including the LEE-encoded Ler (LEE-encoded regulator), GrlA (global 
regulator of LEE activator), and GrlR (global regulator of LEE repressor) (104). The ler gene 
encodes an H-NS-like protein that activates the expression of the LEE genes (156) and is 
encoded on the first operon of the LEE region (177). Ler directly binds to the upstream 
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regulatory region of LEE2, which is downstream of LEE3, to activate transcription of both 
the LEE2 and LEE3 operons (223). Ler up-regulates both intimin and eae-independent 
adherence of STEC O157:H7 to epithelial cells (166). Ler also has supplementary virulence 
properties by regulating the expression of LEE-located genes not required for AE-lesion 
formation, including orf2, orf10, rorf10, orf19, and espF. Furthermore, Ler regulates the 
expression of proteins encoded outside the LEE, including TagA (60). 
The TTSS apparatus is a multicomponent organelle assembled from the products of 
approximately 20 highly conserved genes (74, 201). In the case of E. coli O157:H7 this 
system is used to secrete effectors into host cells that are necessary for the formation of A/E 
lesions (100). The basal TTSS of E. coli O157:H7 requires the products of 22 ORFs that are 
encoded on the first three operons of the LEE (177). The two structures are formed by 
assembly of a series of protein rings spanning both bacterial membranes with a needle-like 
extension or a flagellar hook (4). In EHEC, EscC and EscV are the central components of the 
outer and inner membrane ring structures, respectively (75). EscJ is the lipoprotein that spans 
the periplasm, serving as a link between the inner and outer membrane protein rings (43), and 
the needle is formed from a single protein, EscF (254). The unique feature of the EHEC 
TTSS is the presence of a filamentous extension to the EscF needle, called the EspA filament 
(46), defining a new class of filamentous TTSS (74). The EspA filament is a polymer of the 
translocator protein EspA (51). The EspA filament is a hollow tube that serves as a channel 
to deliver proteins from the bacteria to the host. EspA filaments are also adhesion factors, 
functioning to establish a temporary link between the bacterium and the host cell which 
enables effector protein translocation (38). After the effector proteins are translocated, EspA 
filaments and the needle dissociate from the bacterial cell surface allowing intimate bacterial 
attachment through intimin-Tir interactions (116). Effector proteins are transported to the 
host cell cytoplasm from the edge of the EspA filament through a translocation pore formed 
in the plasma membrane of the host cell by the translocator proteins EspB and EspD (28). In 
addition, EspD is required for the biogenesis of the EspA filaments (116). An additional 
protein called SepL plays a role in the formation of the translocation apparatus (162) by 
interacting with SepD (42). SepL and SepD could be involved in the “switch” from secretion 
of translocator proteins to secretion of effector proteins through the type III machinery (74). 
The best characterized STEC adherence phenotype is intimate or attaching and effacing 
(A/E) adherence, but even within different strains of O157:H7, there is heterogeneity in 
adherence (217). The EHEC bacteria secrete Tir, which is injected into the host cell and 
becomes the receptor for intimin (112). The pattern of phosphorylation of EHEC O157:H7 
Tir after injection into the host cell is different from that of EPEC Tir, and this suggests 
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differences in the function of these proteins within the eukaryotic cell (53). To stimulate the 
reorganization of the actin cytoskeleton below adherent EHEC bacteria, EHEC translocates 
an effector protein, TccP/EspFu (Tir-cytoskeleton coupling protein), which has an Nck-like 
activity (53). This is different from EPEC Tir where Tir is phosphorylated at a tyrosine 
residue and interacts with Nck so as to trigger actin polymerization at the site of bacterial 
adhesion (111). Intimin mediates the intimate binding to the host intestinal cell by binding to 
the Tir receptor (102), and animal models have demonstrated the importance of the LEE 
encoded surface protein intimin in intestinal colonization; also HUS patients develop a strong 
antibody response to intimin as well as other LEE encoded proteins (104). Besides Tir, 
intimin can also bind to eukaryotic receptors such as nucloelin (219) and β-1 integrin (68). 
These interactions may play a role in infection. Numerous intimin subtypes have been 
defined: intimin α, intimin β, intimin γ and intimin δ (2). The particular intimin subtype 
produced by a given A/E E. coli serotype determines its tissue tropism in the intestine. The 
intimin-α producing strains colonize both small and large intestine while the intimin-γ 
producing strains colonize only the large intestine.  
 In addition to LEE-mediated intimate adherence to epithelial cells, EHEC O157:H7 
apparently also uses surface appendages such as flagella, curli and long polar fimbriae, in the 
initial stages of the adherence process (61, 236, 238). An adhesive type IV pili, termed 
hemorrhagic coli pilus (HCP) encoded by the hcpA gene has also been reported to be 
important for the adherence of EHEC O157:H7 (258).  
Once the adherence of bacteria to the intestinal mucosa is established, the bacteria will 
secrete extracellular shiga-like cytotoxins (161). Shiga-like toxins or verotoxins is one of the 
defining characteristics of E. coli O157:H7, and the genes enconding for them are on 
bacteriophages (212). These toxins are considered to be responsible for the manifestations of 
HUS, although the production of toxins alone is insufficient to cause disease because the 
acquisitions of these genes only confers pathogenicity in the appropriate background of 
virulence factors (231). Since the genes are encoded in bacteriophages, it is thought that 
toxigenic E. coli O157:H7 evolved from its recent ancestor, E. coli O55:H7, by acquiring 
shiga-like toxin genes and the large virulence plasmid pO157 through horizontal gene 
transfer (251). The genes encoded for shiga-like toxins are located on a lambdoid 
bacteriophage (160). These toxins are also known as verotoxins as they are active on Vero 
cells (161) and are structurally, genetically and functionally analogous to Shigella toxins 
(161). Shiga toxin (Stx) consists of five identical B subunits that are responsible for binding 
the holotoxin to the glycolipid globotriaosylceramide (Gb3) on the target cell surface, and a 
single A glycanase subunit. The latter removes an adenine residue from 28S RNA preventing 
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the binding of amino acyl tRNA to 60S ribosome that cleaves ribosomal RNA, causing 
protein synthesis to cease (148). The Stx family contains two subgroups, Stx1 and Stx2, that 
share approximately 55% amino acid homology. The majority of isolates of E. coli O157:H7 
produce shiga toxin 2 (Stx2) only; shiga toxin 1 (Stx1) and Stx2 producers are sporadically 
found, but isolates producing Stx1 only are unusual. Shiga toxin 1 is homogeneous, and Stx2 
has several variants, Stx2c, Stx2d, Stx2e, etc. Once secreted in the colon, Stx travels by the 
bloodstream to the kidney. The process of the translocation of the toxin to the bloodstream is 
not well understood. The evidence supports two possibilities that toxin can transfer either 
through the lesions of damaged epithelium (174) or through the intact tissue via trans-cellular 
pathways (1). In the kidney it damages renal endothelial cells and blocks the 
microvasculature through a combination of direct toxicity and induction of local cytokine and 
chemokine production, resulting in renal inflammation and ultimately in HUS (6). Shiga 
toxin also induces apoptosis in intestinal epithelial cells (103). It also facilitates local damage 
in the colon, resulting in bloody diarrhea, haemorrhagic colitis, necrosis and intestinal 
perforation (104).  
While remaining extracellular, these bacteria disrupt the host cell cytoskeletal 
microtubule, intermediate filament (IF), and actin microfilament networks. Other alterations 
to the host epithelial cells include: (a) interruption of intestinal barrier function, including 
increased tight-junction permeability in infected polarized cells (242), paralleled by a 
reduction in transepithelial resistance (TER); (b) loss of mitochondrial membrane potential, 
triggering the formation of deformed mitochondria, resulting in mitochondrial swelling and 
damage (113); (c) inhibition of the cell cycle G2/M phase change (139); and (d) initiation of 
cellular apoptosis (41). The physiological consequences of the infection include a production 
of interleukin-8 and movement of acute inflammatory cells, primarily polymorphonuclear 
cells, to the site of infection (206) and diarrhea. 
Biofilms 
Microbial biofilms are structurally and dynamically complex biological systems 
comprising populations of microorganisms that are concentrated at an interface (usually 
solid–liquid) and typically surrounded by an extracellular polymeric substance (EPS) matrix. 
The aggregates of cells not attached to a surface are refered to as ‘flocs’ but share many of 
the same characteristics as biofilms (86). Biofilms constitute a distinct growth phase that is 
clearly different from its planktonic counterpart (40). The bacteria in biofilms are 
metabolically less active, resistant to environmental stress and engage in more genetic 
exchange. When examined by confocal microscopy, a biofilm appears as sessile bacteria 
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growing in heterogeneous matrix-enclosed microcolonies intermingled with open water 
channels (127). Both the environment and the genome significantly influence biofilm 
formation (86). 
Evidence of the presence of biofilm formation appear early in the fossil record (192). The 
fact that it is common throughout a diverse range of organisms in both the Archaea and 
Bacteria lineages suggests that biofilm formation is an ancient and essential component of 
the prokaryotic life cycle, and is a crucial factor for survival in diverse environments, some 
harsh such as acid mine drainage (58) and hot springs (190).  
Biofilms can be formed either by a single bacterial species or multiple populations of 
different microorganisms including not only bacteria but also fungi, yeast, algae and protozoa 
(127). Single species biofilms are mostly predominant in the clinical environment while 
mixed biofilms are more communly found in natural environments. Even within single 
species biofilms, there is genetic diversity that allows the subpopulations of a sessile 
community to have metabolic heterogeneity. This clearly provides an advantage over 
homogenous planktonic populations (19). Biofilms are also structurally heterogeneous, fluid 
and constantly fluctuating over space and time (87). 
Biofilm growth confers certain advantages to microorganisms. The surface in which they 
form provides a niche, conferring a degree of stability where the cells concentrate in close 
proximity with a combination of their biochemical resources and division of labor (214). 
Biofilm formation also provides protection from a wide range of environmental stresses, such 
as natural surfactants (7), acidification (146), high temperatures (208), desiccation (168), UV 
exposure (64), metal toxicity (234), phagocytosis (131), antibiotics (92) and sanitizers (172). 
Finally, the interaction between communities allows higher rates of gene transfer, which is in 
turn important for evolution and genetic diversity (44, 197). There is also a cost when living 
as a biofilm. Evidence that bacteria develop stress responses within biofilms has been 
reported. The activation of some stress pathways, such as the Cpx or Rcs pathways, has been 
related with roles such as surface sensing through the perception of membrane perturbation 
(65, 170, 225).  
When growing in biofilms, bacteria are protected from environmental stresses like 
antibiotics, chlorine, etc. and also from host defense mechanisms (159). There are three 
different theories to explain the antibiotic resistance within biofilms (227). The first is the 
barrier properties of the slime matrix neutralizes or dilutes antimicrobial agents before they 
can reach the organism embedded in the biofilm. The second theory proposes that the 
resistance is due to decrease in growth and metabolic activity of the cells within biofilms. 
Finally, the third theory suggests that the presence of subpopulations of resistant phenotypes 
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in the biofilm increases the overall resistance of the biofilm (227). It is likely that all three of 
these mechanisms are active. 
Biofilm development 
Biofilm development is not a simple and uniform process, but rather is more complex and 
differentiated than it appears on the surface. Biofilm formation proceeds as a controlled 
developmental sequence, and five stages have been suggested. In stages one and two, a 
temporary association with the surface through weak chemical interactions, such as van der 
Waals forces, occurs followed by strong adhesion. The surface appendages such as pili, 
fimbriae and curli as well as the production of the EPS participate in this stage. Stages three 
and four include the aggregation of cells into microcolonies with consequent growth and 
maturation. During the maturation of the biofilm, the cells continue to grow and produce 
more EPS, causing an expansion of the microcolonies. These large microcolonies then merge 
forming even thicker intricate architectures that include regions filled with water. Stage five 
is characterized by a return to transitory motility where biofilm cells are shed and 
disseminated either individually or in groups into the surrounding environment with a return 
to the planktonic state (171).  
Biofilm structure 
Biofilm structures can be flat or mushroom-shaped depending on the nutrient source, and 
its structure can change according to nutrient conditions, surface and interface properties and 
hydrodynamics (228). For example, biofilms formed in running waters are filamentous and 
patchy, biofilms in quiescent waters have mushroom or mound like structures (86), biofilms 
under sheer stress are stratified and compacted, biofilms from sludge reactors are aggregative 
(136). Regardless of the heterogeneity, biofilms are composed of several microcolonies 
embedded in extracellular polymeric substance (EPS) (82) intermingled with water channels 
(127). This matrix is composed of a mixture of exopolysaccharides, protein, lipids, nucleic 
acids, and other substances. The water channels provide an effective means of exchanging 
nutrients, oxygen and metabolites, enhancing nutrient availability as well as removal of 
potentially toxic metabolites (40). The EPS not only provides the backbone helping with 
bacterial attachment, but it has also been shown to adsorb essential nutrients and growth 
components. Various biofilm matrix polysaccharidic components have been identified such 
as the PIA/PNAG (polysaccharide intercellular adhesion/poly-N-acetylglucosamine) polymer 
encoded by the icaABCD locus in Staphylococcus aureus and Staphylococcus epidermidis, 
colanic acid (E. coli), alginate, glucose and mannose-rich Pel and Pls matrix components 
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(Pseudomonas aeruginosa), cellulose and β-1,6-GlcNac polymer (Salmonella enterica and E. 
coli) (72, 73, 99, 141, 221, 245). In the same way, the EPS provides protection from 
antimicrobials by creating a physical barrier (244). It has also been reported to provide 
protection from a variety of environmental stresses, such as UV radiation, pH shifts, osmotic 
shock, and desiccation (67).  
Regulation and genes involved in biofilm development 
The formation of biofilms by a single species is a well-regulated developmental process 
that results in a complex population of cell types controlled by both genetic factors and 
environmental signals (48). There is also evidence that multiple genetic pathways can be 
utilized to initiate biofilm development (165). The process of biofilm formation initiates 
when bacteria sense certain environmental factors that activate the transition from planktonic 
growth to life on a surface (29, 163, 165). The environmental signals that control this 
transition diverge greatly among organisms. For example, P. aeruginosa will form biofilms 
under most conditions that permit growth (164), but some strains of E. coli K-12 will not 
form biofilms in minimal medium except when supplemented with amino acids (182), and 
many strains of E. coli O157:H7 will make biofilms only under low-nutrient conditions (54). 
Other environmental signals that can also influence initial attachment are osmolarity, pH, 
iron availability, oxygen tension, and temperature (164, 165, 182). 
The regulatory circuitry involved in the lifestyle change between planktonic and biofilm 
life is beginning to be elucitated. In Bacillus subtilis, the switch between flagellar synthesis 
and matrix production is controlled by the master gene regulator SinR through its antagonizer 
SinI. SinI regulates SinR activity, and its abundance and activity changes according to 
environmental conditions (108). The inverse regulation of genes involved in motility and 
matrix components is also apparent in E. coli, P. aeruginosa, S. enterica and Vibrio cholerae, 
but the specific regulatory molecules have not been clearly defined (218, 248). In several 
species, the messenger that links the environmental conditions sensed by the organism to the 
master gene regulators seems to be the cytoplasmic bis-(3’–5’) cyclic dimeric guanosine 
monophosphate (c-di-GMP). Low intracellular c-di-GMP concentrations are found in 
planktonic cells, but these levels increase once the cells have established themselves. 
Furthermore, c-di-GMP can also control the synthesis of various cellular components 
implicated in motility and matrix production as a response to a change in the environment 
(198). 
Large-scale isolation of mutants defective in biofilm formation has identified several 
genes involved in different organisms (91, 135, 164, 182, 187). For example, in P. 
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aeruginosa, sad mutants that were defective in the biogenesis of type IV pili involved in 
twitching motility were also defective in the assembly of a monolayer of cells into 
microcolonies, an important step in the initiation of biofilm formation (164). Escherichia coli 
has also been found to require flagella and pili to initiate the early attachment processes (182) 
and in Vibrio cholerae, motility also appeared to facilitate surface colonization (248). 
However, flagella might not be required within a mature biofilm since genes encoding 
components of the flagellum are repressed soon after the bacteria reach the surface (186). 
The crc locus, which codes for the catabolite repressor protein involved in the regulation of 
carbon catabolism, is also involved in biofilm development by regulating pilA and pilB, 
components of the type IV pili (163). These facts establish a link between nutrient 
availability and biofilm formation in P. aeruginosa. In another study in E. coli, a global 
carbon regulator (CsrA) was also found to have an effect on biofilm formation (98). LPS, an 
important component of the bacterial outer membrane, is also involved in initial surface 
attachment (253). The genes yhiE and yhiF have also been identified as important in the 
adherence of E. coli O157:H7 to epithelial cells as negative regulators for the expression of 
the genes required for the type III secretion system (233). Recently, a transposon 
mutagenesis screening done in E. coli O157:H7 strain EDL933 identified fifty-one biofilm-
negative phenotype (bnp) mutants with reduced biofilm formation (187). Among them were 
the type V-secreted autotransporter serine protease EspP and the enterohemolysin 
translocator EhxD. Other bnp genes encoded structural components (ecpD, csgG, csgB, csgA, 
tolQ, waaL, waaP), enzymes (yahF, yaiH, galU, cls, manC, wbdQ, fcI, aroC, relA, rfaC, 
dsbA), regulators (Z2086, yihF, hns), receptors (Z1178, Z0700, Z3635) hypothetical proteins, 
genes in the curli pili operon (csgG, csgB, csgA) and genes in the LPS biosynthesis operon 
(waaL, waaP, waaD, waaJ) (187).  
Quorum sensing (QS) molecules have also been implicated in the regulation of the 
development of biofilm structures. Quorum sensing has been demonstrated as a key player in 
in control of biofilm development in several other organisms such as P. aeruginosa (49), 
Aeromonas hydrophila (134), Burkholderia cepacia (93) and Serratia liquefaciens (122). 
Escherichia coli does not synthesize N-acylated homoserine lactones (AHL) (3) and has no 
apparent AHL synthase in its genome. However, it contains the sdiA gene that encodes a 
protein of the LuxR family, that possess one domain for binding N-acylated homoserine 
lactones and a second domain for binding DNA. Concordantly, a sdiA mutant has been 
shown to produce threefold less biofilm than a wild type E. coli strain (229). SdiA has also 
been implicated as an important component of the regulation of biofilms by controlling the 
expression of motility and chemotaxis genes in response to indole, which is a byproduct of 
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tryptophan metabolism (129). Contrary to AHL, E. coli strains do secrete the autoinducer-2 
(AI-2) quorum-signaling molecule, encoded by genes of the LuxS family that are involved in 
the universal cell–cell communication signal formation (257). This molecule has been 
involved in the process of biofilm formation (80, 195). 
Importance of biofilms 
In nature, bacterial communities are important in the production and degradation of 
organic matter, the degradation of many environmental pollutants, and the cycling of 
nitrogen, sulfur, and many metals. It is very likely that many of these natural processes are 
carried out by bacteria living as a biofilm, since most of these require the concerted effort of 
bacteria with different metabolic capabilities (48). It has been shown that biofilms are 
implicated in the processing of sewage, in the treatment of groundwater contaminated with 
petroleum products (140) and in nitrification (50). Biofilms also form in many extreme 
environments, in which they have been found to conduct a variety of biological processes, 
such as photosynthesis, nitrogen fixation, and fermentation (48). Biofilm producing bacteria 
can also represent a problem in environmental, industrial and medical processes since they 
can form on many types of surfaces including natural materials (39), medical implants (85), 
plant (45) and animal tissues (143), metals (203, 204), and plastics (226). 
Although mixed population biofilms are predominant in nature, single species biofilms 
are clinically important since they develop on medical implants as well as dead and living 
tissue, contributing to a variety of persistent infections (39). Bacterial biofilms on prosthetic 
valves are the principal cause of endocarditis in patients who have undergone heart valve 
replacement (96). Biofilms on devices such as catheters, and ventilators contribute to 
hospital-acquired infections such as septicemia, urinary track infections and pneumonia (47). 
Biofilm formation can also occur on contact lenses, causing keratitis (59). Biofilm bacteria 
can be up to 1,000-fold more resistant to antibiotic treatment than the same organism grown 
planktonically (77). Moreover, biofilm bacteria are resistant to the host’s antibodies (39), 
contributing to and complicating infections. In addition, biofilms are potential causes in the 
pathogenesis of otitis media (179), tonsillitis (36) and lung infections in cystic fibrosis 
patients (81). Periodontitis is another example of a biofilm-mediated disease that results in 
chronic inflammation of the tissue supporting the gums and can eventually lead to tooth loss 
(123).  
Biofilm formation also causes problems in many industries, particularly in wastewater 
distribution systems, and in food processing industries (30). Bioflms can form on the inside 
of pipes resulting in a reduced flow through the pipe, ultimately clogging the pipe and 
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causing corrosion (31). They are also responsible in some cases for the reduction of heat 
transfer in heat exchangers and cooling towers lowering the equipment efficiency  (189), foul 
reverse osmosis membranes (67), as well as contaminate food processing equipment and 
eventually food products (30). The presence of bacteria in food products or the product 
contact surfaces leads to serious problems and economic losses due to food spoilage and the 
transmission of diseases (30).  
Escherichia coli O157:H7 has been shown to form biofilms on surfaces such as stainless 
steel, glass and plastic surfaces (175, 204), presenting a problem for the food processing 
industry and a public health danger (121, 152). Its persistence in animal manure, manure 
slurry (118), and irrigation water (97) leads to contamination of food crops such as spinach 
(62), lettuce (213) and alfalfa sprouts (66) where its thought that biofilms play an important 
role in persistence on these food crops.  
Although particular biofilms can be detrimental, other biofilms can be beneficial and 
have been exploited to clean up wastewater, off-gas and soils. Biofilms can also be 
potentially used to convert agriculturally derived materials to products of commercial value 
such as alcohols and organic acids (189), in bio-fuel production (242), or as industrial 
catalysts for the production of bulk chemicals (191). 
Escherichia coli biofilms 
Escherichia coli biofilm initiation and maturation can involve many diverse factors and 
its capability to form a biofilm depends significantly on environmental circumstances. Even 
well-demonstrated adhesion factors can be exchanged by others in some cases. Numerous 
different pathways can be used during E. coli biofilm formation, and several regulatory 
mechanisms could coordinate the biofilm adhesion and maturation processes (11). 
In E. coli, motility has shown to have a link with its ability to form a biofilm since its 
flagella allows bacteria to spread along the surface (182, 256). However, it is not a 
requirement, and nonmotile bacteria can still form biofilms under certain conditions where 
the expression of robust adhesion factors may substitute for force generating movements 
during the initial interactions between adhering bacteria and the surface (181, 215). 
The irreversible attachment of the bacteria to surfaces is the result of the direct 
contribution of the adhesive organelles of the fimbrial family. Three classes of fimbriae have 
a part in strengthening the bacteria-to-surface interactions: type 1 fimbriae, curli, and 
conjugative pili (11). Type 1 have been shown to have a role in the formation of IgA-
faciltated secretion of biofilms within the gut (20), and are key for E. coli biofilm 
establishment on abiotic surfaces. Specifically, the type 1 pili FimH adhesin may have a 
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nonspecific binding activity at abiotic surfaces (182). The expression of type 1 pili is induced 
by adhesion and biofilm formation at initial and late stages (207). 
Several small molecules involved in the switch from planktonic to sessile life have also 
been identified such as c-di-GMP. In E. coli, as in other bacteria, a correlation has been 
demonstrated between a high c-di-GMP concentration and biofilm formation vs a low c-di-
GMP concentration and motility (218). Two other small molecules have been identified as 
signals connecting nutrient status to biofilm formation in E. coli: acetyl phosphate (AcP), 
which accumulates intracellularly in the presence of an abundant carbon source and/or a low 
oxygen concentration in the medium (255), and ppGpp that accumulates under nutrient 
starvation conditions (9). 
Ag43, an antigen encoded by the gene flu is a surface autotransporter protein that 
promotes cell-to-cell adhesion and also plays a role in the formation of the three-dimensional 
structure of biofilms (114). In several studies, it has been shown that there is a correlation 
between an increased level of flu expression and E. coli biofilm formation on different 
abiotic surfaces (11, 114). Furthermore, Ag43 has been shown to be directly involved in 
biofilm maturation on abiotic surfaces and on eukaryotic cells, suggesting a link between 
expression of Ag43 and the ability of pathogenic E. coli to adhere to and form biofilm-like 
structures on epithelial cells (5, 216). AidA and TibA are also self-associating proteins 
similar to Ag43 that are involved in bacterial aggregation and enhance biofilm formation 
(216). In E. coli O157:H7 the homologue of Ag43 is the calcium-binding antigen, cah, which 
has also been shown to contribute to biofilm formation of E. coli O157:H7 in glucose-
minimal medium (237).  
Three exopolysaccharides have been identified in the biofilm matrix of E. coli: β-1,6-N-
acetyl-D-glucosamine polymer (PGA) (105), colanic acid (186), and cellulose (260). Surface 
polysaccharides such as the lipopolysaccharide (LPS) and capsular polysaccharide are also 
involved in biofilm formation. Mutations affecting LPS synthesis have been shown to negate 
adhesion to abiotic surfaces and biofilm formation (11, 76) 
The biofilm and plantonic lifestyles involve a different gene expression structure. Gene 
fusion studies indicate that the expression of up to 38% of the E. coli genome is affected by 
biofilm formation (184). This evidence has been supported also with DNA array studies that 
show between 5% and 12% of the E. coli genome shows differences in gene expression in 
sessile vs planktonic life (11, 207). Even if these studies indicate that there is a general 
pattern of gene expression, the different experimental conditions and the use of different 
strains and different time points complicates the analysis, underscoring the possibility that 
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global analyses might not be appropriate for dealing with the extreme complexity of gene 
expression in time and space that resides within a biofilm (10). 
Role of curli in biofilm formation 
The curli fibers are thin and coiled fimbriae-like extracellular structures that attach to 
proteins of the extracellular matrix such as fibronectin, laminin, and plasminogen on human 
cells (167). Furthermore, curli are also important for biofilm formation to abiotic surfaces by 
facilitating initial cell–surface interactions and subsequent cell–cell interactions (241). Genes 
involved in curli production are encoded in two operons: the csgBA operon, encoding the 
structural components, and the csgDEFG operon, encoding the transcriptional regulator 
(CsgD) and the curli export apparatus (CsgE-G) (89). CsgA is the major structural subunit 
while CsgB acts as the nucleator protein. A third gene, csgC is in the csgBA operon, but no 
transcript has been detected and no role has been found in the curli biogenesis (88). In the 
absence of CsgB no curli are assembled and CsgA is secreted from the cell (34). CsgD acts 
as a global regulator and can function as an activator as well as a repressor (22). In E. coli 
O157:H7, CsgD promotes biofilm formation by activating adhesion positive factors, the csg 
operons and yaiC gene, and represses biofilm negative effectors such as yagS and pepD (22). 
The roles of CsgE, CsgF and CsgG are still not completely understood. CsgG is an outer 
membrane lipoprotein required for the stability and secretion of CsgA and CsgB. CsgE and 
CsgF are periplasmic proteins that physically interact with CsgG but its role is still unknown 
(34). 
Regulation of curli expression is extremely complex and responds to several 
environmental cues. The region between the csgDEFG and the csgBA operons is one of the 
largest in E. coli. The most important protein in this complex regulatory network is CsgD, 
which is a transcriptional regulator in the FixJ/UhpA family (88). CsgD positively regulates 
the csgBA operon but it does not regulate its own expression. It is uncertain what activates 
CsgD expression, but it has been proposed that the phosphorylation of a conserved residue 
might be involved in its activation (199). Numerous transcriptional regulators such as the 
EnvZ/OmpR two-component system (183, 185, 241), CpxR (56), RcsCDB, RpoS, H-NS, 
IHF, Crl, Fis and MlrA have been found to impact curli expression as well as other adhesins, 
according to different environmental and stress conditions such as temperature, osmolarity, 
pH and oxygenation (22, 183, 185). Two regulators, H-NS and RpoS, associated with 
responses to environmental conditions, have also been shown to play a role in modulating 
biofilm formation, but their role is still not completely clear (11). Crl interacts with RpoS to 
facilitate RpoS binding to the csgBA promoter region (8). RpoS also modulates curli gene 
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expression by activating MlrA expression, which acts as a positive transcriptional regulator 
of cgsD (23). The EnvZ/OmpR two-component system influences curli gene regulation the 
most. It responds to changes in osmolarity and regulates the porins OmpF and OmpC (180). 
EnvZ acts as a sensor that transmits to the OmpR regulator which in turn positively regulates 
cgsD gene expression (200). The Cpx system is activated in response to envelope stress. 
CpxA is the sensor kinase and CpxR is the response regulator that negatively regulates both 
curli operons (186). The Rcs pathway also responds to membrane stress and negatively 
regulates csgD expression (65). This pathway is also required for biofilm formation (56). 
Therefore, the regulation of curli is correlated to the capability to form biofilms. However, 
since Rcs and Cpx both negatively regulate curli expression, curli may play a role only 
during the intial steps of biofilm formation, possibly for initial adhesion and then turned off 
as the Cpx and Rcs pathways become active during the later stages of biofilm formation (34).  
Studies have suggested that some genes involved in biofilm formation may also play a 
role in adherence and colonization of host tissues (117, 124, 137, 154). Of particular 
importance is the study by Puttamreddy (188) that showed that the ability of E. coli O157:H7 
strain EDL933 to form biofilms is positively linked to adherence to the two distinctly 
different human epithelial-like cells suggesting a possible role of early biofilm formation in 
the attachment of the bacterium to host tissues. While these studies support a critical role of 
biofilm activity in adherence, it is still necessary to directly show that biofilm formation 
contributes to adherence in other strains, especially those lacking in vitro biofilm forming 
activities. To investigate the extent to which biofilm formation contributes to adherence in 
strains Sakai and 86-24, it was first determined if non-biofilm forming strains (Sakai and 86-
24) can be induced to produce biofilms in vitro. Biofilm induction was accomplished by 
growing the different strains under nutrient limiting conditions at different temperatures and 
measure the biofilms produced over time. Second, it was determined if biofilm related genes 
found in EDL933 are essential for cell adherence in Sakai and 86-24 strains by deleting 
genes previously linked to biofilm formation and testing the ability of Sakai and 86-24 
mutants to adhere to epithelial cells. Next, the adherence of EDL933, Sakai and 86-24 to 
epithelial cells was measured after growing under conditions determined to induce biofilm 
formation. Finally, it was determined if transcriptional differences occur in Sakai in the 
presence and absence of epithelial cells through a microarray analysis involving biofilm 
essential genes.  
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Abstract 
Escherichia coli O157:H7 is a human pathogenic bacterium that causes food-born 
infections with symptoms that range from mild diarrhea to hemorrhagic colitis and in a small 
percentage of hemolytic uremic syndrome (HUS).  Tissue adherence is a critical factor in its 
pathogenicity, however, it has not been completely defined. The formation of biofilms is a 
mechanism that confers bacteria several advantages when growing under less favorable 
conditions. Biofilm development, structure, and regulation on abiotic surfaces have been 
extensively studied for E. coli O157:H7, but its role during pathogenesis or colonization of 
hosts still remains to be fully understood, mainly because most strains have not been shown 
to produce biofilms under normal laboratory culture conditions. However, an important 
linkage between biofilm formation and cellular adherence in E. coli O157:H7 strain EDL933, 
a strong in vitro biofilm-producing strain has been established. In this study we investigated 
the extent to which biofilm formation contributes to adherence in strains Sakai and 86-24 that 
lack in vitro biofilm forming activities. We determined that non-biofilm forming strains 
might be induced to produce biofilms in vitro when grown under nutritionally deficient 
media and sub-optimal temperature, indicating that these strains might have the ability to 
form biofilms. We also deleted 6 genes previously determined to be related to biofilm 
formation (aroC, ecpD, hlyD, csgA, relA and yaiH) in both 86-24 and Sakai strains. A 
significant reduction in adherence to both cell lines was demonstrated for all of the biofilm 
gene negative mutants, providing evidence that biofilm related genes found in EDL933 are 
also essential for cell adherence in Sakai and 86-24. We also determined that biofilm induced 
strains adhere better to the epithelial cells. Finally, we determined through a microarray 
analysis that a non-biofilm forming strain up-regulates curli associated genes in the presence 
of cultured epithelial cells. We have offered evidence that the adherence of E. coli O157:H7 
to epithelial cells is strongly linked to biofilm formation and that at least the initial steps in 
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biofilm formation play important roles in the cellular adherence of E. coli O157:H7 to the 
epithelium. This linkage might be further explored to understand how biofilm production in 
this pathogen at the mucosal epithelium interface contributes to its high persistence and 
intermittent shedding in the cattle as well as playing a role in the cellular adherence to human 
intestines and contribute to its pathogenicity. 
 
Introduction 
Escherichia coli O157:H7 is a human pathogenic bacterium that causes food-born 
infections with symptoms that range from mild diarrhea to hemorrhagic colitis. Most patients 
recover from the infection within the first 10 days, but in a small percentage of patients (up to 
10%), particularly young children and the elderly, the infection may lead to hemolytic uremic 
syndrome (HUS). HUS is characterized by acute renal failure, hemolytic anemia and 
thrombocytopenia. It can also cause neurological complications in a quarter of the patients 
and chronic renal disease in around half of the survivors. The case-fatality rate ranges from 
3% to 5% (63).  
Many virulence factors have been identified for this pathogen. This includes a 
pathogenicity island known as locus of enterocyte effacement (LEE) that contains all of the 
essential genes that cause attaching-effacing (A/E) lesions on intestinal epithelial surfaces 
through activation of a Type III secretion system (22). The A/E lesion is characterized by the 
loss of microvilli and accumulation of cytoskeletal components to form a pedestal on the host 
cell upon which the bacteria rests (16). The adhesin encoded by eae on the LEE is a surface 
protein called intimin that facilitates the intimate binding to the host intestinal cell by binding 
to the bacteria-encoded receptor Tir that is translocated into the eukaryotic cell and 
positioned on the cell surface (24). Once the adherence of bacteria to the bowel mucosa is 
established, the bacteria will secrete extracellular shiga-like cytotoxins (43) or verocytotoxin 
(VT) that contributes to an intense inflammatory response and damage to the epithelium.  
Tissue adherence is a critical factor in its pathogenicity because it is the originating 
incident that determines its pathogenic potential. Adherence, however, has not been 
completely defined, mainly because of the numerous potential fimbrial operons and other 
factors that alter the host cell physiology (26). Biofilm formation is increasingly being 
recognized as a significant contributor to disease in other bacterial species (47), but its 
linkage to pathogenesis in E. coli O157:H7 has not been well documented mainly because 
most strains have not been shown to produce biofilms under normal laboratory culture 
conditions (10, 32, 34). Nonetheless, recent studies have shown that unlike wild type cells, 
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biofilm-negative mutants adhere poorly or not at all to Hep2 and T84 epithelial cells, 
establishing an important linkage between biofilm formation and cellular adherence in E. coli 
O157:H7 strain EDL933, a strong in vitro biofilm-producing strain (49, 50). While these 
studies support a critical role of biofilm activity in adherence in strain EDL933, it is still 
necessary to directly show that biofilm formation contributes to adherence in other strains, 
especially those lacking in vitro biofilm forming activities. In order to investigate the extent 
to which biofilm formation contributes to adherence in strains Sakai and 86-24, three specific 
aims were followed: 1) Determine if non-biofilm forming strains (Sakai and 86-24) can be 
induced to produce biofilms in vitro. 2) Determine if biofilm related genes found in EDL933 
are essential for cell adherence in Sakai and 86-24 strains. 3) Determine the transcriptional 
differences in a non-biofilm forming strain in the presence and absence of epithelial cells. 
These objectives aim to prove the working hypothesis for this study that the adherence of E. 
coli O157:H7 to epithelial cells requires the initiation of biofilm formation. The linkage 
between biofilm formation and adherence of E. coli O157:H7 could be used to understand 
how biofilm production in this pathogen at the mucosal epithelium interface contributes to its 
high persistence and intermittent shedding in the cattle as well as playing a role in the cellular 
adherence to human intestines and contribute to its pathogenicity. 
 
Materials and Methods 
Bacterial Strains and Growth Conditions. Escherichia coli O157:H7 strains EDL933 
(ISM1536), ISM1536+pISM31 specR (ISM1978), 86-24 (ISM1356) and Sakai (ISM2059) 
were used for this study and are described in Table 2. Strain EDL933 is associated with the 
first O157:H7 outbreak in 1982 (51). Strain Sakai caused the largest O157:H7 outbreak to 
date in 1996 in Sakai, Japan (42) and strain 86-24 caused a hemorrhagic colitis outbreak in 
the US during 1986 (18). Deletion mutants for strains 86-24 and Sakai were constructed as 
described below. Deletion mutants from strain EDL933 were obtained from the Minion 
laboratory stocks and were used as controls (50). Bacteria were routinely grown at 37°C, 180 
rpm in LB broth, except where indicated. Antibiotics (Sigma Chemical Co, St. Louis, MO) 
were used at the following concentrations except where noted: ampicillin (50 µg/ml); 
kanamycin (50 µg/ml); gentamicin (6 µg/ml). For mutant screening, LB plates were 
supplemented with kanamycin. Strains that contained the temperature-sensitive plasmid 
pRedET were grown at 30°C. Reproducible growth of mutant strains was confirmed by 
OD600 readings.  
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Table 2. E. coli strains and plasmids 
Strain/Plasmid Genotype or description* Source 
E. coli strains   
DH5α F- φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 λ- thi-1 gyrA96 relA1 
Invitrogen 
ISM1536 E. coli O157:H7 EDL933 N. Cornick 
ISM1978 E. coli O157:H7 EDL933+pISM31 specr F. C. Minion 
ISM2022 E. coli O157:H7 EDL933Δeae Kanr +pISM31 specr (50) 
ISM1356 E. coli O157:H7 86-24 N. Cornick 
ISM2161 E. coli O157:H7 86-24+pISM31 specr This study 
ISM2258 E. coli O157:H7 86-24 +pRedET Ampr This study 
ISM2259 E. coli O157:H7 86-24 Δeae Kanr This study 
ISM2268 E. coli O157:H7 86-24 Δeae Kanr+pISM31 specr This study 
ISM2265 E. coli O157:H7 86-24 ΔaroC Kanr This study 
ISM2270 E. coli O157:H7 86-24 ΔaroC Kanr+pISM31 specr This study 
ISM2266 E. coli O157:H7 86-24 ΔcsgA Kanr This study 
ISM2276 E. coli O157:H7 86-24 ΔcsgAKanr+pISM31 specr This study 
ISM2279 E. coli O157:H7 86-24 ΔecpD Kanr This study 
ISM2286 E. coli O157:H7 86-24 ΔecpD Kanr+pISM31 specr This study 
ISM2263 E. coli O157:H7 86-24 ΔexhD Kanr This study 
ISM2272 E. coli O157:H7 86-24 ΔexhD Kanr+pISM31 specr This study 
ISM2284 E. coli O157:H7 86-24 ΔyaiH Kanr This study 
ISM2274 E. coli O157:H7 86-24 ΔyaiH Kanr+pISM31 specr This study 
ISM2059 E. coli O157:H7 Sakai N. Cornick 
ISM2162 E. coli O157:H7 Sakai+pISM31 specr This study 
ISM2257 E. coli O157:H7 Sakai +pRedET Ampr This study 
ISM2260 E. coli O157:H7 Sakai Δeae Kanr This study 
ISM2269 E. coli O157:H7 Sakai Δeae Kanr+pISM31 specr This study 
ISM2264 E. coli O157:H7 Sakai ΔaroC Kanr This study 
ISM2271 E. coli O157:H7 Sakai ΔaroC Kanr+pISM31 specr This study 
ISM2285 E. coli O157:H7 Sakai ΔrelA Kanr This study 
ISM2277 E. coli O157:H7 Sakai ΔrelAKanr+pISM31 specr This study 
ISM2280 E. coli O157:H7 Sakai ΔecpD Kanr This study 
ISM2287 E. coli O157:H7 Sakai ΔecpD Kanr+pISM31 specr This study 
ISM2262 E. coli O157:H7 Sakai ΔexhD Kanr This study 
ISM2273 E. coli O157:H7 Sakai ΔexhD Kanr+pISM31 specr This study 
ISM2288 E. coli O157:H7 Sakai ΔyaiH Kanr This study 
ISM2275 E. coli O157:H7 Sakai ΔyaiH Kanr+pISM31 specr This study 
pKD4 Derivative of pANTSγ that contains an FRT-flanked Kanr gene from pCP15 (8) 
pRedET Derivative of pSC101, Ampr, temperature sensitive, carries lambda red 
recombinase  
Gene 
Bridges 
pISM31 pMHE6 expressing GFPuv G. Phillips 
*Ampr = ampicillin resistant; Kanr = kanamycin resistant; Gmr = gentamicyn resistant, Cmr=chloramphenicol 
resistant. 
 
Plasmids. For the deletion-insertion mutagenesis, plasmid pKD4 and pRedET were used. 
To visualize the strains in the microscopic adherence assay, all the bacterial strains were 
transformed with pISM31, a derivative of pMHE6 (15) expressing GFPuv (7).  
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Cell Cultures. Adherence assays with cultured intestinal cell lines are often used to 
determine differences in pathogenicity among EHEC strains in vitro (41, 60). T84 human 
colon epithelial cells (ATCC CCL-248) and HEp2 human laryngeal epithelial cells (ATCC 
CCL-23) were grown in either 25 or 75 cm2 tissue culture flasks (Falcon) with DMEM/F12 
(Invitrogen) supplemented with 5% fetal bovine serum and 50 µg/ml gentamicin at 37°C 
with 5% CO2. Confluent cells were trypsinized using 0.05% trypsin for 10 min at 37°C in 5% 
CO2 and reseeded into flasks or plates. 
Presence of EDL933 Biofilm-Related Genes in Sakai and 86-24. To determine if the 
previously established biofilm related genes are present in both Sakai and 86-24, an online 
search of the 68 genes (Table 3) was completed for the Sakai strain (NCBI database; GI: 
47118301). For the 86-24 strain, which had not been sequenced, a PCR for each individual 
gene was performed. The reaction was performed with reaction volumes of 50 µl per well 
(39.25 µl of water, 5 µl 10x buffer without Mg, 1.5 µl µl of 50 mM MgCl2, 1 µl of dNTPs at 
10 mM each, 1µl of each primer at 10 mM, 0.25 µl of Taq polymerase at 5U/µl and 1 µl of 
crude DNA extract) using the following thermal cycling conditions: 95ºC for 5 min; 34 PCR 
cycles of 95ºC for 30 sec, 55ºC for 30 sec, and 72ºC for 30 sec; and a final extension of 5 
min at 72°C. Amplification of products was confirmed by electrophoresis. 
Assays for Biofilm Formation. To determine if biofilms could be produced by strains 
86-24 and Sakai, they were grown in a nutritionally deficient medium, Minimum Salt Media 
(MSM) at different temperatures under stationary conditions. Biofilm formation was 
monitored at different time points (24h, 48h and 72h). The production of biofilms was 
determined using a microtiter plate assay as described previously (12, 49). This assay detects 
biofilm-adherent bacteria in the bottom of a 96-well microtiter plate by staining it with 
crystal violet. Overnight MSM cultures were inoculated into fresh Costar 96 well flat bottom, 
non-treated polystyrene plates (Corning, Inc., New York, NY) containing 150 µl of MSM per 
well. After incubation at different temperatures (4°C, room temperature, 30° and 37°C) and 
time points of 24, 48 and 72 h, the plate was washed twice with water, and the adherent 
bacteria were stained with 0.01% crystal violet (175 µl/well) for 20 min. After staining, the 
plates were washed again three times with water. At this point, biofilms were visible as a 
violet ring on the side of each well and as a generalized staining of the bottom of the well. 
Plates were then air dried and de-stained with 200 µl of 80% ethyl alcohol for 15 min. As a 
measure of relative amounts of biofilms formed, the optical density was measured at 595 nm 
using a Spectra MAX 190 spectrophotometer (Molecular Devices, Union City, CA). All 
experiments were performed in triplicate; a well containing medium only was used as a 
blank. 
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Table 3. List of biofilm related genes 
Number Locus Tag Gene name Product/Function 
1 Z3917  Hypothetical protein 
2 Z4881 gatY Fructose-1,6-bisphosphate aldolase 
 Z5856 pyrB Aspartate carbamoyltransferase 
4 Z2256  Unknown protein associated with Rhs element 
5 Z5890  Partial putative integrase 
6 L7020 espP Putative exoprotein precursor 
7 Z3635  Membrane transport protein YfdV 
8 Z3182 hisD L-histidinal: NAD+ oxidoreductase 
9 Z4625 acrE Protein affects cell membrane permeability 
10 Z0472 yaiH Beta-lactam binding protein AmpH 
11 Z1555  Hypothetical Protein 
12 Z2436 ynaJ Hypothetical Protein 
13 Z1921  Unknown protein encoded by CP933X 
14 Z0151 ecpD Putative fimbrial chaperone protein 
15 Z1457  Hypothetical Protein, Encoded by BP-933W/ Putative DNA 
binding protein of BP-933W 
16 Z3592 aroC Chorismate synthase 
17 Z2026 cls Cardiolipin synthase 
18 L7049 hlyB Hemolysin transport protein 
19 Z3497  glpQ Glycerophosphodiester phosphodiesterase 
20 Z4099 relA GDP/GTP pyrophosphokinase 
21 Z5049 waaL LPS biosynthesis enzyme 
22 Z3199/Z3200 wbdP/ Per Putative glycosyl transferase/ Perosamine synthetase 
23 Z5050 waaD LPS biosynthesis enzyme 
24 Z2163 ydeH Hypothetical Protein 
25 Z1675/Z1676 csgB/csgA Minor curlin subunit precursor/ Curlin major subunit, coiled 
surface structures 
37 Z5054 waaP LPS biosynthesis enzyme 
38 Z4328  Hypothetical Protein 
39 Z0700  Putative receptor 
40 Z3918  Putative chaperone protein 
41 Z1494  Unknown protein encoded by BP-933W 
42 Z0021  Hypothetical Protein 
43 L7047 hlyC Hemolysin protein 
44 Z1977 ychM Hypothetical Protein 
45 Z0408/Z0409 yahE/ yahF Hypothetical Protein/ Putative oxidoreductase subunit 
46 Z3197 fcI Fucose synthetase 
47 Z0904 ybgC Acyl-CoA thioester hydrolase 
48 Z4327  Hypothetical Protein 
49 Z5392 dsbA Protein disulfide isomerase I 
50 Z1177/Z1178 terF Partial putative phage inhibition protein/ Putative receptor 
51 Z3215/Z1261 wcaH GDP-mannose mannosyl hydrolase 
52 Z5734 cadA Lysine decarboxylase 1 
53 Z5568 thiE Thiamine-phosphate pyrophosphorylase 
54 Z5252 rbsB D-ribose transporter subunit RbsB 
55 Z5181 yidE Hypothetical protein 
56 Z5053 waaI LPS biosynthesis enzyme 
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Table 3. (continued)    
Number Locus Tag Gene name Product/Function 
57 Z4595 mdh Malate dehydrogenase 
58 Z4470 tdcA DNA-binding transcriptional activator TdcA 
59 Z4365 dkgA 2,5-diketo-D-gluconate reductase A 
60 Z3405 mglB Galactose-binding transport protein; receptor for galactose taxis 
61 Z2705 Lpp Murein lipoprotein 
62 Z2661 sodC Superoxide dismutase 
63 Z2452 Tpx Thiol peroxidase 
64 Z1673 csgD DNA-binding transcriptional regulator CsgD 
65 Z1034 dps DNA starvation/stationary phase protection protein Dps 
66 Z0805 ybeJ Glutamate and aspartate transporter subunit 
67 Z0351 yagS Hypothetical protein 
68 Z0298 pepD Aminoacyl-histidine dipeptidase 
 
Construction of Deletion Mutants. Six genes previously determined to be essential for 
biofilm formation in EDL933 (aroC, ecpD, ehxD, csgA, relA and yaiH) (49, 52, 62) were 
deleted in both 86-24 and Sakai strains. An eae deletion mutant was also constructed to use 
as a negative adherence control. Deletion mutants were constructed following a one-step 
gene inactivation method adapted from Datsenko and Warner (8) and Puttamreddy and 
Minion(50). Briefly, a kanamycin cassete from isolated plasmid pKD4 was amplified by 
PCR using primers containing target homologous sequences for each of the genes as well as 
the sequences for amplyfing the kanamycin gene (49, 50) (Table 4). Products of 
amplification were purified with the MolBio purification kit following the manufacturer’s 
instructions. Thirty µl of this product at a concentration of 100 ng/µl in water was 
electroporated into strains containing the temperature-sensitive plasmid pRedET (Gene 
Bridges, Dresden, Germany) encoding lambda red recombinase. Cells were prepared by 
induction with 0.4% L-arabinose for 1 h at 30°C and washed 4 times with 10% glycerol. 
Fourty µl of chilled cells were placed into chilled 0.2 cm electroporation cuvettes and 
electroporated (2000V, 129 Ω) using a BTX electro cell manipulator (model 600, Harvard 
Apparatus, Holliston, MA). After electroporation, cells were incubated in SOC broth for 1 h 
and then plated on selective media and incubated at 37°C overnight. Isolated colonies were 
then picked and the kanamycin insertion confirmed by PCR using primers that anneal to a 
region within the kanamycin cassette and a region immediately downstream of the gene that 
was being replaced.  
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Table 4. Primers 
Primer  Sequence (5’→3’) 
Recombineering 
Test F TGTGTAGGCTGGAGCTGCTTC 
eae F ATTATGCCCCGACTAAAACAATACATATTTTAGCCGGGGTGGTTATGG
AATGTGTAGGCTGGAGCTGCTTC 
eae R TATTAATATAATTTATTTCTCATTCTAACTCATTGTGGTGGAGCCATAA
CCATATGAATATCCTCCTTA 
eae test R CCGGAAGATAAAATCCGATC 
csgA F ACAACGTTAATTTCCATTCGACTTTTAAATCAATCCGATGGGGGTTTTA
CAATTACAATTAACCCTCAC 
csgA R CCCGAAAAAAAACAGGGCTTGCGCCCTGTTTCTTTAATACAGATGATG
TATAATACGACTCAC 
csgA test R TAACGCATTCATATTCTTCT 
yaiH F TGAATAAAGGCAAACTGGTCGCTATCAACCGTTTGCCTTCAGAGTATT
AATGTGTAGGCTGGA 
yaiH R AGTAGTATAAATACGCTCAGTTACCTTCATTCAATTTATGGACACCACC
GCATATGAATATCC 
yaiH test R GCCCTTTGCAATCCATCAATG 
ehxD F CCAAAAAAGACAGTTTATATGCATATTTATATCAGTTGCAGGCATAAC
GTTGTGTAGGCTGGAGCTGCTTC  
ehxD R ATTATTTCAGAAATCTATATCATATAAAAAGCCAATATGTTATTTATAT
AATATGAATATCCTCCTTA 
ehxD test R ACATAGATAA TCTTTACAAG 
ecpD F CTGGTACAAGGTTGCATTCCTGGCGATGTTAAAAAGAATCCGTTTATTT
TTGTGTAGGCTGGA 
ecpD R GCAGGCAAACCTTATTTTCGCGAATTTAATCTTTCTACAGACAG
CAAGGACATATGAATATCCTCCTTA 
ecpD test R TGTTGAGCATAAGGTTTGCCA 
relA F GTAGATACAGTATATATCAATCTACATTGTAGATACGAGCAAATTT
CGGCTGTGTAGGCTGGA 
relA R TAGTTGCGATTTGCCGATTTCGGCAGGTCTGGTCCCTAAAGGAGAG
GACGCATATGAATATCC 
relA test R GTACTTTTCTCGCGCGTTAAA 
aroC F ACGCTACTGGCAAGCAGGGCCAGCAGCGCAATCGCGGTTTTGTTC
ATTTTTGTGTAGGCTGGA 
aroC R GATTTATAAAGATTAAGTAAACACGCAAACACAACAATAACGGAG
CCGTGCATATGAATA 
aroC test GGCGGCCCGTGAACATTTCGC 
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Table 4. (Continued)   
Primer  Sequence (5’→3’) 
RT-PCR  
Z1787 RT PCR F ACTGTCACTGTCAACTCTCAG 
Z1787 RT PCR R GGCAACCACTCAGGAAAATG 
arcA RT PCR F GAAGACGAGTTGGTAACACG 
arcA RT PCR R CTTCCAGATCACCGCAGAAGC 
Fis_RT_F TGACGTACTGACCGTTTCTACCGT 
Fis_RT_R CTGGTTACCACGGGTGTATTGCAT 
Z1676_RT_F GCAGCCGCAGCAGGTTATGATTTA 
Z1676_RT_R ATCTTTGCCCGGTTGCTACTACCT 
Z1673_RT_F AGATTACCCGTACCGCGACATTGA 
Z1673_RT_R TTTGCGTAAAGTAGCATTCGCCGC 
Z1213_RT_F GACAACGTCACTTGCCACCACAAA 
Z1213_RT_R AACCTGGTCAACACGGTGGAGTTT 
Z3635_RT_F CGCTTCCTGCAGCCCTATTTGTTT 
Z3635_RT_R GCTGCTTCTGCATGGGTACGTTTA 
 
Construction of GFPuv Expressing Strains. To visualize the strains in the microscopic 
adherence essay, all of the bacterial strains were transformed with pISM31, a derivative of 
pMHE6 (15) expressing GFPuv (7). Two µl of isolated plasmid was electroporated (1800V, 
129 Ω) into cells prepared as above. 
Microscopic Adherence Assays. The ability to adhere to HEp2 and T84 cells of both 
wild type strains and the constructed mutants was examined using a previously described 
microscopic analysis (50). Briefly, monolayers grown on 22 mm2 glass cover slips (Corning, 
NY) were infected with the GPFuv transformed strains. To grow monolayers in the 
coverslips, these were washed with 1 N HCl for 10 min, and 3 times with sterile water and 
placed in 24-well tissue culture plates (Costar polystyrene, Corning, NY). Cells (4 X105) 
were seeded onto the glass coverslips in each well and grown until 80-95% confluency. If 
necessary the media was changed during this period. Before the infection, monolayers were 
washed 3 times with Hanks Balanced Salt Solution and replenished with media without 
antibiotics. For the infection, an overnight culture of bacteria in LB or a 48h culture at room 
temperature in MSM was used. For LB cultures a 1:20 dilution in fresh LB was done and 
grown for another 2 h. Approximately 4 x 106 bacteria were added to each well and the plates 
were then incubated at 37°C with 5% CO2 for 3 h. Following infection, the cover slips were 
then washed 3 times with PBS to remove non-adherent bacteria. The cells were fixed using 
4% paraformaldehyde in PBS for 10 min. Again, coverslips were washed twice with PBS and 
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treated with BSP buffer (250 mg bovine serum albumin, 100 mg saponin, per 100 ml PBS) 
for 5 min. 
After this treatment, two additional washes with BSP were done. Alexa Fluor 546–
labeled phalloidin (Invitrogen) diluted 1:200 in BSP was added for 1 h to stain for F-actin 
(56). Coverslips were then washed twice with BSP and then mounted on a glass slide using 
mounting solution with DAPI (4', 6-diamidino-2-phenylindole). Once the slides were dry, 
cover slips were sealed using clear nail polish. Samples were analyzed and images were 
captured using a FluoView100 confocal laser scanning microscope with blue argon, green 
helium neon and red helium neon lasers and analyzed with FV10 AW 2.1 software. 
Quantitative Adherence Assays. To quantify the adherence of wild type strains and 
constructed mutants, 2 different quantitative adhesion essays were performed in duplicate 
with monolayers of HEp2 and T84 cells. Cells (4 X105) were seeded in 24-well tissue culture 
plates (Costar polystyrene, Corning, NY) and grown until 80-95% confluency. If necessary 
the media was changed during this period. On the day of the infection, monolayers were 
washed 3 times with Hanks Balanced Salt Solution and replenished with media without 
antibiotics. For the infection, an overnight culture of bacteria in LB or a 48h culture at room 
temperature in MSM was used. For LB cultures a 1:20 dilution in fresh LB was done and 
grown for another 2 h. Approximately 4 x 106 bacteria were added to each well and the plates 
were then incubated at 37°C, 5% CO2 for 3 h. At this point, bacterial cultures were serially 
diluted to 10-5, 10-6 and 10-7 and plated onto LB plates to enumerate bacteria. The tissue 
culture plates were then incubated at 37°C, 5% CO2 for 3 h. Following infection, the plates 
were washed 3 times with phosphate-buffered saline (PBS) to remove non-adherent bacteria. 
The cells were then detached and lysed using 0.5 ml of 0.1% Triton X-100 for 15 min with 
shaking. A serial dilution in PBS was then prepared (102, 103, 104 and 105) and dilutions 
plated to enumerate the adherent bacteria. The percentage of adherence was calculated by the 
following formula: number of bacteria adhered/number of bacteria added to the well  100. 
Adherence to the tissue culture plates without monolayers was also determined and proved to 
be negligable (results not shown).  
Preparation of Cultures and RNA Isolation. RNA from bacterial cells both in contact 
with and in the absence of epithelial cells was obtained. Six biological replicates were 
collected on different days. Each replicate consisted of bacterial cells in the absence of 
epithelial cells and bacterial cells in the presence of epithelial cells. For the RNA obtained 
from bacterial cells in the presence of epithelial cells, HEp2 cells (4 x 105) were seeded in 
T150 tissue culture flasks (Cellstar, Greiner Bio-One) and grown until 80-95% confluency. If 
necessary the media was changed during this period. Before the infection, monolayers were 
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washed 3 times with Hanks Balanced Salt Solution and replenished with media without 
antibiotics. For the infection, an overnight culture of Sakai strain in LB was diluted 1:20 in 
fresh LB broth and grown for another 2 h. Approximately 4 x 106 bacteria were added to 
each plate, and the plates were then incubated at 37°C, 5% CO2 for 3 h. Following infection, 
the media was collected and the cells were then detached and lysed using 0.5 ml of 0.1% 
Triton X-100 for 15 min with shaking. The solution was then collected and mixed with the 
previously collected media. The solution was then centrifuged 5 min at 10,000 x g, room 
temperature and the bacterial pellet resuspended in 1 ml of Ambion RNAlater solution by 
vortexing for 15 sec. The solution was stored at -70°C until the RNA was isolated. For the 
bacterial cells in the absence of epithelial cells, the same procedure was followed except no 
HEp2 cells were seeded into the T150 tissue culture flask and no lysis of cells was done. 
RNA isolation was conducted using the Ambion Tri Reagent Solution and manufacturer´s 
instructions. Each 100 µl sample was then treated with 4 µl of DNAse (Turbo DNAse, 
Ambion, Austin, TX) for 35 min at 37°C. Samples were then purified and concentrated using 
Microcon YM-30 columns (Millipore, Billerica, MA). The quantity of the RNA samples was 
determined using a Nanodrop spectrophotometer (Wilmington, DE), and the quality of the 
RNA was assessed using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).  
cDNA Synthesis. The first strand cDNA was synthesized with 200 U Superscript III 
reverse transcriptase (Invitrogen); 1 mM each of dATP, dCTP, and dGTP; 200 µM dTTP; 
400 µM aminoallyl dUTP; 10 mM dithiothreitol; and 1× RT buffer (Invitrogen). The reaction 
was allowed to proceed overnight at 42°C. cDNA was quantified with a Nanodrop 
spectrophotometer as described before. 
Microarrays and Data Analysis. An array with 70 synthesized oligonucleotides was 
constructed (Table 5). Oligonucleotides were designed based on the sequences of the biofilm 
related genes for E. coli O157:H7 (49) and purchased from Integrated DNA Technologies 
(Coralville, IA). Probes were spotted on Epoxide slides (Invitrogen) by using a MicroGrid 
robot (Biorobotics). Following printing, slides were kept in a dehumidifier at room 
temperature until their use. Six biological replicates were used consisting of RNA extracted 
from bacteria in contact with epithelial cells (treatment) paired with RNA from bacteria in 
absence of epithelial cells (control). Assignment was random. cDNA synthesis was done as 
described above with 5µg of RNA for each sample. RNA was hydrolysed with 10 mM 
EDTA and 10 mM sodium hydroxide for 10 min at 65°C and neutralized with 500 mM 
HEPES pH 7.0. The aminoallyl-labelled cDNA was then purified using the UltraClean PCR 
Clean-Up kit (Mo Bio Laboratories). Labeling, reaction clean-up, hybridization, and pre- and 
post-hybridization washes were all conducted as described previously using Cy3 and Cy5 
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dyes (GE Healthcare) (46). Samples were paired for hybridization on a two-color microarray 
slide. Dye assignments to control and treatment samples with Cy3 and Cy5 dye were 
reversed for three of the arrays to account for variation in labeling efficiencies. Scanning, 
image segmentation, and normalization were conducted as described previously (37). To 
determine the differential expression between control and treatment, a student t-test was 
performed for each probe. The p-values were then used to estimate the q-values using the 
method of Storey & Tibshirani (57). Fold changes of gene expression between control and 
treatment were estimated by taking the inverse natural logarithm of the estimated mean 
treatment difference from the linear mixed model analyses. 
Real-time PCR (qRT-PCR). Genes identified as differentially-transcribed in the 
presence of HEp2 cells by microarray analysis were confirmed by real-time RT-PCR. These 
include csgA, csgD, Z3635 and cadA, gene Z1787 of E. coli O157:H7 strain Sakai as an up-
regulated gene control (ref) and arcA as a reference gene for within sample normalization of 
mRNA abundance. The global regulator Fis that has been implicated as a negative regulator 
of curli was additionally included in the analysis.  The transcription level of the same genes 
for the EDL933 strain was also investigated. A test plate with all test and reference gene 
primer sets was initially run to test inhibition and determine the ideal working dilutions. As 
template for the test plate, a mixture of equal volumes of all RNA samples was prepared to a 
final concentration of 4 ng/µl (this was dilution 1). A 1:3 serial dilution of the template was 
then prepared for a total of 8 dilutions. The plate was organized so that each primer set was 
tested with these 8 dilutions of the template. The qScript One-Step SYBR qRT-PCR Kit 
(Quanta Biosciences) was used on the Mx3005P QPCR System with MxPro 4.1 software 
(Stratagene, La Jolla, CA). The reaction was performed in a 96 well plate with a reaction 
volume of 15 µl per well (3.8 µl of water, 7.5 µl 2x reaction mix, 0.6 µl of each primer at 2.5 
µM, 5 µl of sample RNA at a concentration of 4 ng/µl) using the following thermal cycling 
conditions: a cDNA synthesis step at 50ºC for 30 min; an RT deactivation/Taq activation step 
at 95ºC for 10 min; 40 PCR cycles of 95ºC for 30 sec, 53ºC for 30 sec, and 70ºC for 30 sec; 
and a melt curve step of 95ºC for 10 min, 55ºC for 30 sec, and 95ºC for 30 sec. To determine 
the 3 best dilutions for the samples, a linear regression was calculated, and the dilutions 
having the highest R2 values were chosen. Samples were diluted to the 3 chosen dilutions 
from the test plate and run under the same conditions as described above. The Ct values 
obtained were averaged for the biological replicates for each dilution and corrected for 
efficiency of amplification and the dilution factor (Ct*). The fold change was calculated 
using the following formula: 2 (Ct*of WT reference gene - Ct*of M reference gene) / 2(Ct*of WT test gene - Ct*of M test 
gene) (17). 
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Table 5. Oligonucleotide sequences used in microarray analysis 
Oligonucleotide 
Name Sequence (5’→3’) 
bnp1|Z3917_7-56 TTTGCGTGGTGCGCCCCACTTCAGGATGCTGCAGATCTGGAAATTGCAAC 
bnp2|Z4881|gatY_153-
202 AACCAATGCACAACTCTCGGGATACGATTACATTTATGAAATCGTGAAAC 
bnp3|Z5856|pyrB_18-67 TCAGAAACATATCATTTCCATAAACGACCTTAGTCGCGATGACCTTAATC 
bnp4|Z2256_14-65 
AAGAAAAAGATCTTGGGACTTATAAAAAATCAACCCTTAAAACTGAAAA
AAT 
bnp5|Z5890_691-740 CTGGAGTTAAAGCGTATCCCTGAGTTGCTTGACAAAATAGACAGCTACAC 
bnp6|L7020|espP_1537-
1586 CTGAATAATACTGCTGACTATATCTATCACGGTAACATAAACGGGAATCT 
bnp7|Z3635_361-411 TATGGTGATTCCGTATCAACAGGTTTAGTGGTAGCAATTATTTCTATTATT 
bnp8|Z3182|hisD_169-
218 AAGTTTGATAAAACCACGGTTACCGCACTGAAGGTGTCTGCTGAGGAAAT 
bnp9|Z4625|acrE_121-
170 GTTCATATTGTAAAAACGGCCCCGTTAGAAGTTAAGACTGAATTACCAGG 
bnp10|Z0472|yaiH_296-
345 AATTGCTCGACCAGGGGACCGTGAAGTTAAACGATCCGCTAAGTAAATAT 
bnp11|Z1555_587-636 ATTCGCAGGATGACCAGTTAATAAAAGAAGTGTTGTATCAGGATTTCCAG 
bnp12|Z2436|ynaJ_141-
190 GTGGACGACATCAATGTATGTGATTCAGTCATCGATGATTTTTGTTTATA 
bnp13|Z1921_607-656 AAATTACCACCACTTGAGAAATACAAAAACGTATATTACAACATGTCAGA 
bnp14|Z0151|ecpD_4-53 CTTATGTTTCCCTTGGTTAAAAAAACGGTTAGTGCATTATTTGTG AGT AC 
bnp15|Z1457_159-208 TAAACAAACAATTAGCCCTAACAAATTCACAAGCGTGTATATATTCGAAG 
bnp16|Z3592|aroC_848-
897 GGCAGCAAATCATTGCTCATATGGCACTGAAACCGACCTCCAGTATTACC 
bnp17|Z2026|Cls_819-
868 GATTATTTATTCCTGCGACTGGGAGATTGAAACAGGGAAACGTATTCTAC 
bnp18|L7049|hlyB_1760-
1809 TTATTAGAGAACTAAAAGAAGGGTACAATACTATTGTTGGAGAACAGGGC 
bnp19|Z3497|glpQ_964-
1013 GAATACACAACTGATGTGAATCAGTTATATGATGCTCTGTATAACAAAGC 
bnp20|Z4099|relA_10-59 GTAAGAAGTGCACATATCAATAAGGCTGGTGAATTTGATCCGGAAAAATG 
bnp21|Z5049|waaL_751-
800 GAGATGACCGCAAAGCTAACGTATAAACTTCAACAAACTAATAGTTCTTA 
bnp22|Z3199|wbdP_963-
1013 
ATTTGACGCTATTGCATTAGGGAAAAAAGTTATACTATCTGACATAGATG
T 
bnp23|Z5050|waaD_156-
209 
CTTTGTTAATGATAATTGTAGTATTCATAGGGTTGGATTCAGTCGCATATA 
TAA 
bnp24|Z2163|ydeH_507-
556 TAAATTGGTTAATGATACCTACGGGCATTTAATCGGCGATGTAGTATTAC 
bnp25|Z1676|csgA_307-
356 ACTCTTGATCAGTGGAACGGTAAAGACTCTCATATGACAGTTAAACAATT 
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Table 5. (Continued) 
Sequence Name Sequence (5’→3’) 
bnp26|Z2086_196-245 ATTAACATGAGGAAATATGAGCCTTATCTGCTCAATGATAATTCCATACT 
bnp27|Z3660|yfeA_23-72 GTGAGAGTAGTGTACTCATGTTTGTGGAGCATAACCTGATAAAAAATATC 
bnp28|Z5214_1830-1882 
TTTGCAAGTACTTTACTACGATTATGAGAATAAGAATAAGCCTACAAAGGA
GA 
bnp29|Z5051|waaJ_401-
452 TCTGTAAGGGTTCATTGAACGAGTTAATAGCATTAGAGTTTAAAGATGAATA 
bnp30|Z1670|csgG_402-
451 AAATATCATGGTTGAAGGTTCGATTATCGGTTATGAAAGCAATGTCAAAT 
bnp31|Z1213_386-435 ATCAGGTTCACCATAAACTGAATCATCTTGAAGAAAAACTCCACCGTGTT 
bnp32|Z1213_386-435 ATCAGGTTCACCATAAACTGAATCATCTTGAAGAAAAACTCCACCGTGTT 
bnp33.1|Z2012|galU_177
-226 GGTTACACACTCATCTAAAAACTCTATTGAAAACCACTTTGATACCAGTT 
bnp33.2|Z2013|hns_116-
16 AACGTCGCGAAGAAGAAAGCGCGGCTGCTGCTGAAGTTGAAGAGCGCACT 
bnp34|Z3195|manC_638-
687 CATCTGTTTATCTTGAGGAATTGAGAAAATTTAGACCTGACATTTACAAT 
bnp35|Z0340_426-479 
AAATGAGACAATCCAGACCCCAAATATAAATTGCTATACTACATGTATTTTA
AC 
bnp36|Z1676|csgA_307-
356 ACTCTTGATCAGTGGAACGGTAAAGACTCTCATATGACAGTTAAACAATT 
bnp37|Z0905|tolQ_157-
206 GAAGATAAATTCTGGTCTGGAATCGAACTCTCTCGCCTCTATCAAGAGAG 
bnp38|Z5054|waaP_335-
384 CATTTATTATTACCGAAGATCTGACACCAACCATAAGTCTTGAAGATTAC 
bnp39|Z4328_373-431 
AGCATGTATGATAAAAAACTATCTGATATTTACCTTGAAAATATCCATAAAC
AAGAATC 
bnp40|Z0700_1-52 ATGGAACTTAAAAAATTGATGGAACATATTTCTATTATCCCTGATTACAGAC 
bnp41|Z3918_41-90 GTATAAGTTGCCATAGAGAGAACTCCTTCAGGAACTCTTTCCGAGGGAAG 
bnp42|Z1494_289-338 CTCCAGTTGCAGAAATACAACCAGCGACGGCTTGAGTATAACGATATGAT 
bnp43|Z0021_217-266 TTAACACAGAACGCTTTAAGGTTTAAAGTCGGAAGTCGTCATTATATTAT 
bnp44|L7047|hlyC_186-
237 TCTGGAATGTGAGGTAAAATATATAAATGATGTAACATCTTTGTATGCAAAA 
bnp45|Z1977|ychM_757-
806 GATCTGCCTAATTCAGAATTCACGCTAACCTGGGATTCTATTCGCACACT 
bnp46|Z0409|yahF_6-56 AGTTAAAATAGTCATTAAACCGAATACCTATTTTGATTCTGTCTCGCTGAT 
bnp47|Z3197|fcI_206-
262 
TTTTAGCTAACAGTTCTTATCCTGCCGATTTTATATATGAGAATATAATGATA
GAGG 
bnp48|Z0904|ybgC_103-
152 GCACGCACAGAGATGCTGCGTCATCATCACTTCAGTCAACAGGCGCTGAT 
bnp49|Z4327_1-51 ATGTTTTTTGATAAAAGTACCGATGACTTTTTTATTACGTACTACAGTGCG 
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Table 5. (Continued) 
Sequence Name Sequence (5’→3’) 
bnp51.1|Z1177|terF_155-
204 TCTTTTATAATAATTTGTCTTCTCCTGAGGGGGCAGTCAGGCTCGTTACC 
bnp51.2|Z1178_1489-
1539 TTTATGACTGACTTCTCCAACAAGATTGTCTCTTATTCCATAAATGATAAC 
Z3215|cah_26-75 TTGCCACGGTAGTGCGCTCCACACCGCTTGTCTCTCTCGACTTTATTGTC 
Z5734|cadA_397-451 
ACTAAAGCACTGTTTAAATATGTTCGTGAAGGTAAATATACTTTCTGTACT
CCTG 
Z5568|thiE_7-56 CANCCTGATTTTCCTCCTGTACCTTTTCGTNTANGACTGTACCCGGTGGT 
Z5252|rbsB_287-336 TAGGTAATGCTGTGAAGATGGCTAACCAAGCGAACATCCCGGTTATCACT 
Z5181|yidE_631-680 GTTGAGAACCCTAACCTGCATGATTTAGCCATTAAAGATGTACCGATTCT 
Z5053|waaI_668-726 
ATGTATTATTGAATGGTAAAGTGAAGTTTATTTCGGAGAAATATAATACC
CGATATAGT 
Z4595|mdh_53-104 TACTGTTAAAAACCCAACTGCCTTCAGGTTCAGAACTCTCTCTGTATGATT 
Z4470|tdcA_602-651 AAACTAATATGGGGTACTACAGCGAACTGCTTACTACGTTACAAAGAAAT 
Z4365|dkgA_274-323 AGCCTGAAAAAACTCCAGCTTGATTATATCGACCTCTACTTAATGCACTG 
Z3405|mglB_82-131 ATTGGTGTAACAATCTATAAGTACGACGATAACTTTATGTCTGTAGTGCG 
Z2705|lpp_79-128 ATCGATCAGCTGTCTTCTGACGTTCAGACTCTGAACGCTAAAGTTGACCA 
Z2661|sodC_100-149 GTTGGGCAGTCAATTGGTAGCGTCACCATTACTGAAACCGATAAAGGTCT 
Z2452|tpx_132-181 GGGTAAACGCAAAGTGCTGAACATTTTCCCGAGTATTGATACCGGTGTTT 
Z1673|csgD_117-168 ATTACATAATATTCAACGTTCTCTGGACGATATCTCTTCAGGCTCTATTAT 
Z1034|dps_110-159 TTATCCAGTTTATTGATCTTTCTTTGATTACCAAACAAGCGCACTGGAAC 
Z0805|ybeJ_136-185 CACCGTGAATCTTCAGTACCTTTCTCTTATTACGACAATCAGCAAAAAGT 
Z0351|yagS_6-55 GGCGTTTACCTATGAACGAGTGAACACCCCCGCCGAGGCGGCACTTAGCG 
Z0298|pepD_1054-
1103 ACCATGACTGACAATAACGTAGAAATTCACTGTCTGATCCGTTCTCTGAT 
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Results 
EDL933 Biofilm-Related Genes in Sakai and 86-24. A total of 68 different genes have 
been identified  as being involved in biofilm formation in previous studies (Table 3). Fifty-
one of these distinct genes/intergenic regions were identified with the construction of a mini-
Tn5 transposon insertion library in E. coli O157:H7 strain EDL933 (49). For this study, it 
was first necessary to determine if all of the previously established biofilm related genes are 
present in other E. coli O157:H7 strains, specifically in those lacking in vitro biofilm forming 
activities in normal culture conditions such as Sakai and 86-24. To confirm this, either an 
online search (Sakai strain) or a PCR (86-24) was performed with the primers listed in Table 
3. The presence of all of the 68 genes was unequivocally confirmed for both strains.  
Assays for Biofilm Formation. Escherichia coli O157:H7 EDL933 has been shown to 
form biofilms under normal laboratory culture conditions, whereas the ability to produce 
biofilms in strains 86-24 and Sakai has been poorly defined (32, 34, 49, 50). It has been 
previously established that culture conditions affect the development of biofilm formation 
and that a more robust biofilm forms under low nutrient conditions (10). In this study, the 
ability of both Sakai and 86-24 strains to grow as biofilms was tested. Biofilm production 
was induced by growing strains in a nutritionally deficient medium (MSM) and different 
growth temperatures (4°C, room temperature, 30°C and 37°C) monitoring biofilm formation 
at different time points (24, 48 and 72 h). Biofilm formation was determined quantitatively 
with a crystal violet assay, measuring the OD at 595nm (Figure 1 and appendix A) and 
normalizing for bacterial growth. Reproducible growth of the three strains in MSM was 
confirmed by OD at 600nm showing no differences in growth between the strains (results not 
shown). As expected, the presence of strong biofilms was detected at all time points when 
growing at room temperature, 30°C and 37°C for strain EDL933. For strain 86-24, a 
statistically significant OD595, was detected at room temperature after growing the strain 48 
hours, indicating the presence of a weak biofilm at this temperature and time point. For the 
Sakai strain, biofilm formation was also detected when growing at room temperature after 48 
hours and also at 30°C after 24 hours of growth, indicating the presence of biofilm at this 
temperatures and time points for this strain. These results indicate that all of the tested E. coli 
O157:H7 strains (EDL933, 86-24 and Sakai) are capable of growing as biofilms, and that 
biofilm formation can be induced in vitro when certain conditions pecular to each strain are 
met, such as lower growth temperatures and nutritionally deficient media.   
 56 
 
Figure 1. Comparison of biofilm formation by E. coli O157:H7 strains EDL933, 86-24 
and Sakai. Bacteria were grown at different growth temperatures (4°C, room temperature, 
30° and 37°C) and monitored at different time points (24, 48 and 72 h). Bars represent the 
corrected mean (mean – blank) OD at 595 nm plus the standard error of three replicates. * 
indicates a significant difference from the blank at p < 0.01.  RT = room temperature. 
 
Linkage of Biofilm Genes with Adherence of 86-24 and Sakai to Epithelial Cells. 
Recent studies have shown that unlike wild type cells, biofilm-negative mutants of E. coli 
O157:H7 EDL933 adhere poorly or not at all to HEp2 and T84 epithelial cells, establishing 
an important linkage between biofilm formation and cellular adherence in this strain (49, 50). 
To directly show that biofilm formation contributes to adherence in other strains, especially 
those lacking in vitro biofilm forming activities, six genes previously determined to be 
essential for biofilm formation in EDL933 (aroC, ecpD, ehxD, csgA, relA and yaiH) (49, 52, 
62) were deleted in one or both strains. eae, the gene that codes for intimin, was also deleted 
to use as a negative adherence control. Both microscopic and quantitative adherence assays 
were performed to assess the ability of the mutants to adhere to both cell lines. The 
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microscopy assay showed the absence of adhered deletion mutants in both strains to both cell 
lines after 3 hours of infection (Figures 2 and 3 and appendix B). When comparing adherence 
from 1-6 hours, maximum adherence occurred at 3 hours, and the reproducible growth of the 
three strains in tissue culture media was confirmed by OD at 600 nm showing no differences 
in growth between the strains (data not shown). The presence of adherent wild type cells for 
both cell lines and strains was confirmed, and the negative eae deletion mutant also failed to 
adhere as expected since this gene has been previously shown to be an important component 
in the bacterial cellular adherence (24).  
Adherence was also measured quantitatively confirming the inability of the mutants to 
adhere to both cell lines after a 3 hour infection time (Figure 4 and Table 6). All mutants 
showed a significantly decreased adherence (p<0.01) when compared with the wild type. 
Adherence of the negative eae deletion mutant was also significantly reduced as expected. 
 
Table 6. Percent adherence to epithelial cells. 
 HEp2     T84    
Strain % 
Adherence 
Relative  
%* 
SD p-value % 
Adherence 
Relative 
% 
SD p-value 
EDL933 wt 87.19  5.18  87.77  4.50  
EDL933 Δeae 15.15 17.38 1.22 7.69E-10 19.79 22.54 2.10 7.88E-08 
EDL933 ΔaroC 0.48 0.55 0.10 3.02E-09 0.59 0.67 0.20 9.96E-09 
86-24 wt 5.98  1.34  5.93  1.14  
86-24 Δeae 0.54 9.04 0.19 9.43E-06 0.35 5.89 0.09 3.40E-05 
86-24 ΔaroC 0.52 8.66 0.09 4.51E-05 0.63 10.64 0.40 6.16E-05 
86-24 ΔecpD 0.55 9.16 0.27 5.07E-05 0.51 8.56 0.27 4.59E-05 
86-24 ΔexhD 0.57 9.56 0.20 5.00E-05 0.55 9.30 0.09 4.19E-05 
86-24 ΔyaiH 0.99 16.50 0.23 8.44E-05 1.19 20.13 0.74 2.18E-04 
86-24 ΔcsgA 0.73 12.25 0.27 6.35E-05 0.71 11.96 0.26 5.63E-05 
Sakai wt 6.12  1.01  4.37  0.43  
Sakai Δeae 1.29 21.16 0.47 7.79E-06 0.67 15.39 0.30 3.72E-06 
Sakai ΔaroC 0.57 9.24 0.02 6.24E-06 0.65 14.93 0.11 1.35E-06 
Sakai ΔecpD 0.57 9.34 0.20 9.31E-06 0.85 19.45 0.16 2.31E-06 
Sakai ΔexhD 0.77 12.56 0.13 8.30E-06 0.59 13.46 0.12 1.27E-06 
Sakai ΔyaiH 0.81 13.18 0.24 9.64E-06 0.60 13.63 0.16 1.83E-06 
Sakai ΔrelA 0.80 13.08 0.15 8.78E-06 0.84 19.20 0.11 1.52E-06 
* Relative %, Relative adherence percentage = % adherence of mutant / % adherence of 
wildtype; SD, standard deviation of percent adherence.  
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Figure 2. Microscopic images of the adherence to HEp2 cells by Escherichia coli 
O157:H7. Escherichia coli O157:H7 bacteria are transformed with a GFP expressing plasmid 
and are seen green attached to epithelial cells. Epithelial cells are labeled with Alexa Fluor 
546-labeled phalloidin for F-actin (red) with their nuclei labeled with DAPI (4',6-diamidino-
2-phenylindole) (blue). An example of one of the biofilm mutants is shown (ΔaroC), along 
with the wild type and negative adherence control (Δeae) strains. 
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Figure 3. Microscopic images of the adherence to T84 cells by Escherichia coli 
O157:H7. Escherichia coli O157:H7 bacteria are transformed with a GFP expressing plasmid 
and are seen green attached to epithelial cells. Epithelial cells are labeled with Alexa Fluor 
546-labeled phalloidin for F-actin (red) with their nuclei labeled with DAPI (4',6-diamidino-
2-phenylindole) (blue). An example of one of the biofilm mutants is shown (ΔaroC), along 
with the wild type and negative adherence control (Δeae) strains. 
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Figure 4. Quantitative adherence of Escherichia coli O157:H7 deletion mutants to T84 and HEp2 cells. The adherence of the 
deletion mutants, wild type and to T84 and HEp2 the !eae (negative adherence control) was determined with a quantitative 
adherence assay. Bars represent the mean plus the standard error of four replicates. All mutants were significantly different from 
the wild type at p < 0.01. 
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EDL933 wild type as well as ∆eae and ∆aroC mutants were used in both microscopic 
and quantitative adherence essays as controls. As expected, both eae and ∆aroC EDL933 
mutants showed a significantly reduced adherence to both cell lines. Interestingly, assays 
with both cell lines showed a significant increased difference in the adherence of the wild 
type EDL933 when compared to wild type 86-24 and Sakai strains. 
All of the deletion mutants failed to adhere to both cell lines after 3 hours of infection as 
determined by both the microscopic and quantitative adherence essays, indicating a linkage 
between biofilm formation and adherence to epithelial cells in both strong biofilm-forming 
strains such as EDL933 and poor biofilm-forming strains such as 86-24 and Sakai. 
Having established a linkage between biofilm formation and adherence, we also 
investigated the adherence of EDL933, Sakai and 86-24 strains to HEp2 cells after the 
bacteria were grown under low nutrient conditions in vitro. After growing the three strains in 
MSM at room temperature for 48 hours and vortexing the cultures prior to infecting the 
monolayers, a quantitative adherence assay showed that the adherence of Sakai and 86-24 
was increased in comparison to the strains grown under normal culture conditions (LB at 
37°C) (Figure 5). The adherence of EDL933 was unchanged. 
Microarray Analysis. To compare the transcriptional profile of biofilm-related genes in 
Sakai in the presence of HEp2 cells to its profile in the absence of epithelial cells, a 
microarray with 70 probes was contructed. Statistical analysis showed 6 genes that were 
differentially expressed in Sakai in contact with HEp2 cells when compared to strain in the 
absence of HEp2  (p < 0.01) and (q < 0.1); 3 genes were down-regulated and 3 were up-
regulated (Table 7). All of the up-regulated genes were associated with the curli operon. 
Real-Time PCR (qRT-PCR). Transcription levels of the differentially-transcribed genes 
shown by the microarray analysis were confirmed by qRT-PCR. These include csgA, csgD, 
Z3635 and cadA. The gene Z1787 of E. coli O157:H7 strain Sakai was used as an up-
regulated gene control since this gene has been previously shown to be up-regulated in E. 
coli O157:H7 in the presence of epithelial cells (21). The global regulator Fis that has been 
implicated as a negative regulator of curli (52) was additionally included in the analysis. 
Microarray data was validated by the qRT-PCR since the transcription levels determined by 
qRT-PCR correlated with the expression levels identified in the microarray in terms of 
direction of differential expression (Figure 6 and appendix C).   
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Figure 5. Quantitative adherence of Escherichia coli O157:H7 strains EDL933, Sakai and 
86-24 to HEp2 cells after the strains were grown under biofilm inducing conditions in 
minimal medium. Control cells (LB) were grown overnight in LB medium, diluted and 
grown an additional 2 h in LB medium. Bars represent the mean plus the standard error of the 
mean of three replicates. * indicates a significant difference from LB growth (p < 0.01). 
 
 
The transcription level of the same genes for the EDL933 strain was also investigated. It 
was determined that both curli genes (csgA and csgD) were up-regulated in relation to the 
Sakai strain, while Z3635, cadA and fis were down-regulated (Figure 7). 
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Table 7. Differentially-transcribed biofilm genes of Sakai in the presence of HEp2 cells. 
Locus Gene ID Function *FC p-Value q-Value 
Z1676 csgA Curli major subunit 9.58 4.85 X 10-
5 
0.003437 
Z1670 csgG Curli production 
assembly/transport component 
3.36 0.002048 0.04838 
Z1673 csgD DNA-binding transcriptional 
regulator CsgD 
2.77 0.004212 0.06199 
Z1213  Hypothetical Protein -1.21 0.004809 0.06199 
Z3635  Membrane transport protein 
YfdV 
-1.31 0.005250 0.06199 
Z5734 cadA Lysine decarboxylase 1 -1.70 0.043149 0.589135 
• FC = Fold Change; positive values indicate up-regulation when strain is in contact with HEp2 
and negative values indicate down-regulation.  
 
 
 
Figure 6. qRT-PCR analysis of differentially expressed biofilm related genes of Sakai in 
presence of HEp2 cells. 
!"#$$%
!&#$$%
!'#$$%
!(#$$%
$#$$%
(#$$%
'#$$%
&#$$%
"#$$%
!"#$#% !"#&% !"#'% !$%&% !()(*% &"'
+,-,%
./
01
%23
4-
5,
%
 64 
 
 
 
 
 
 
 
 
 
 
Figure 7. qRT-PCR analysis of differentially expressed biofilm related genes of strain 
EDL933 in comparison to strain Sakai.  
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Discussion 
The formation of biofilms is a mechanism that confers bacteria several advantages when 
growing under less favorable conditions. Biofilm development, structure, and regulation on 
abiotic surfaces have been extensively studied for several microorganisms including E. coli 
O157:H7. Biofilm formation on biotic surfaces such as epithelial cells could be important in 
the pathogenesis of this organism, but its role during pathogenesis or colonization of hosts 
still remains to be fully understood. Tissue adherence is also a critical factor in the 
pathogenicity of this bacterium, since it is the first stage in the infectious disease process and 
the originating incident that determines its pathogenic potential. Adherence, however, has 
also not been completely defined, mainly because of the numerous potential fimbrial operons 
and other factors that alter the host cell physiology (26). Some studies have shown that some 
genes involved in biofilm formation are also involved in adherence and colonization of host 
tissues (30, 31, 38). In E. coli O157:H7 this relationship was shown in recent studies from 
our laboratory that established an important linkage between biofilm formation and cellular 
adherence in E. coli O157:H7 strain EDL933, a strong in vitro biofilm-producing strain (49, 
50). While these studies support a critical role of biofilm activity in adherence in strain 
EDL933, it is still necessary to directly show that biofilm formation contributes to adherence 
in other strains, especially those showing poor in vitro biofilm forming activities such as 
Sakai and 86-24. Understanding this important linkage and the way this organism interacts 
with host cells may help identify new targets for therapy as well as provide valuable 
information on the effects that adhesion and biofilm formation have on the tissue to which it 
adheres. 
In order to investigate the extent to which biofilm related genes contributes to adherence 
in strains Sakai and 86-24, the first step was to confirm that these two strains have the genes 
that have been reported to be associated with biofilm formation. The next step was to 
determine if these two strains have the ability to produce biofilms and if that ability can be 
induced in vitro. Both Sakai and 86-24 strains do not grow as biofilms when growing in rich 
media such as LB broth at 37°C, conditions that could be described as being ‘ideal’. It has 
been established that culture conditions affect the development of biofilm formation and that 
a more robust biofilm forms under low nutrient conditions (10). Biofilm formation has also 
been linked to molecules involved in carbon metabolism establishing a linkage between 
nutrient availability and biofilm formation (20, 44). It is also expected that microorganisms 
grow as biofilms when subjected to environmental stresses such as sub-optimal temperature 
(53). Biofilm formation was induced for Sakai and 86-24 as well as the strong biofilm 
producer EDL933 when growing under low nutrient and sub-optimal temperature conditions. 
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The conditions however, were particular to each strain. Biofilm formation was measured at 
different time points when growing at different temperatures for the three different strains. 
For 86-24, a biofilm was detected at room temperature after growing the strain 48 hours; for 
the Sakai strain, biofilm formation was detected when growing at room temperature after 48 
hours and also at 30°C after 24 hours of growth. However, the biofilms detected for both 86-
24 and Sakai strains were weak when compared to the biofilm formed by EDL933 strain. 
More studies are necessary to establish if other environmental conditions might induce 
stronger biofilms for these two strains. It is also recommended that other methods other than 
the crystal violet assay are used for establishing the presence of biofilms to confirm these 
results. 
Biofilm formation is controlled by both genetic factors and environmental signals (9), 
and the process of biofilm formation initiates when bacteria sense certain environmental 
factors that activate the transition from planktonic growth to life as a biofilm (5, 44, 45). 
There is also evidence that multiple genetic pathways can be utilized to initiate biofilm 
development (45). Interestingly, it appears that both Sakai and 86-24 strains are capable of 
initiating biofilm formation under different environmental conditions. Whether this is 
correlated with the activation of different genetic pathways still remains a question.  
In an effort to study the cellular interactions of the intestinal mucosa and E. coli 
O157:H7, two types of human epithelial-like cells were used: HEp2, a human laryngeal 
epidermoid carcinoma cell line, and T84, a human colonic epithelial cell line. Recent studies 
have shown that unlike wild type cells, biofilm-negative mutants of E. coli O157:H7 strain 
EDL933 adhere poorly to HEp2 and T84 epithelial cells establishing an important linkage 
between biofilm formation and cellular adherence in E. coli O157:H7 (49, 50). Since this is a 
strong biofilm producing strain in vitro, it was important to directly show that biofilm 
formation also contributes to adherence in strains 86-24 and Sakai. To this end, six biofilm-
related genes (aroC, ecpD, ehxD, csgA, relA and yaiH (49, 52, 62) were deleted in both 86-
24 and Sakai strains after which the mutants were tested for adherence to human HEp2 and 
T84 cells and compared to the wild type strain for each. relA has been demonstrated to be 
required for efficient biofilm formation in L. monocytogenes, S. mutans and E. coli (4, 33, 
58). aroC (chorismate synthase) has been shown to be involved in biofilm formation in 
Streptococcus mutans (55). The role of ehxD in biofilm formation is still not completely 
clear, but one possibility is that it acts as an independent translocator and transports 
components that are important for biofilm formation (49). csgA encodes the curlin subunit, 
and is part of the csgBA and csgDEFG operons that are necessary for curli formation (48). 
Curli pili are highly adhesive proteinaceous structures required for bacterial adherence to 
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surfaces as well as bacteria-to-bacteria binding, and are critical for both primary surface 
colonization and subsequent biofilm development (48). Both ecpD and yaiH were 
demonstrated to be essential for E. coli O157:H7 biofilm formation (49, 50). An eae deletion 
mutant was also constructed to use as a negative adherence control. The adhesin encoded by 
eae on the LEE is a surface protein called intimin that facilitates the intimate binding to the 
host intestinal cell by binding to the bacteria-encoded receptor Tir that is translocated into the 
eukaryotic cell and positioned on the cell surface (24). Intimin was chosen since it is the only 
factor that has been demonstrated to play a role in intestinal colonization in vivo (40). Wild-
type strains adhered to both cell lines, but all of the deletion mutants, including the negative 
control failed to adhere to both cell lines after 3 hours of infection as determined by both the 
microscopic and quantitative adherence essays. These results indicate these genes are linked 
to biofilm formation and to adherence to the two different human epithelial-like cells. We 
also investigated the adherence of EDL933, Sakai and 86-24 strains to HEp2 cells after the 
bacteria had been induced to form biofilms in vitro. After growing the three strains in MSM 
at room temperature for 48 hours, a quantitative adherence assay showed that the adherence 
of Sakai and 86-24 was increased in comparison to the strains grown under normal culture 
conditions (LB at 37 °C), indicating that biofilm formation directly contributes to adherence, 
lending further credence to the overall hypothesis that at least the initial steps in biofilm 
formation play important roles in the cellular adherence of E. coli O157:H7 to the epithelium. 
Since these results are from human epithelial cell lines and do not represent the complex 
intestinal environment and the multicellular composition of the bovine gut, we did not 
address our overall hypothesis directly. However, it has been demonstrated that there are no 
differences in the adherence of E. coli O157:H7 strains of human origin when compared to 
distinct strains of bovine origin (11). 
The E. coli O157:H7 population consists of different groups that vary genetically, but not 
much is known about the variation in gene expression between distinct O157:H7 strains and 
how that relates to biofilm formation and cell attachment. Variable expression of genes that 
are shared between strains might cause differences in the ability to cause disease (1). 
Consequently, understanding the phenotypic differences among different strains is important 
in order to advance our understanding of the molecular mechanisms that govern the variation 
in clinical illness. In these studies, both biofilm formation and adherence appears to be 
significantly increased in the EDL933 strain when compared to wild type 86-24 and Sakai 
strains, reinforcing the linkage between biofilm formation and adherence, since the strong 
biofilm former strain adhered better to epithelial cells. A prior study that compared Sakai 
with a strain that caused an epidemic in 2006 demonstrated that Sakai had less ability to 
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colonize epithelial cells (2). This was correlated with the ability of Sakai to cause severe 
disease in germ-free mice but the histopathological damage was minimal (14). Yet, further 
studies are needed to answer why different strains present different phenotypes and what role 
these differences have in terms of colonization and pathogenesis. EDL933 is closely related 
to Sakai (39), but their adherence and biofilm formation abilities differ significantly. Why 
strains Sakai and 86-24 lost their ability to constitutively form biofilms in vitro under normal 
growth conditions like EDL933 remains unresolved. 
Studies describing gene expression profiling of E. coli O157:H7 are limited and have 
either focused on phylogenetic analysis (13, 64) or changes of gene expression in response to 
different environmental conditions (3, 54). The limited studies that have described the gene 
expression profile of this pathogen in the context of infection models (21, 29) have not 
addressed the differences in gene expression in the context of biofilm formation. Thus, in this 
study we performed a comparative gene expression analysis of 70 biofilm-related genes in E. 
coli O157:H7 strain Sakai grown in the presence of cultured epithelial cells relative to growth 
in the absence of epithelial cells. Statistical analysis showed 5 genes that were differentially 
expressed in Sakai in contact of HEp2 cells when compared to incubation in the absence of 
HEp2 cells (p < 0.01; q< 0.1), 2 genes were down-regulated and 3 were up-regulated. All of 
the up-regulated genes were associated with the curli operon. These results were confirmed 
with a qRT-PCR that showed the same direction of differential expression. The levels of 
expression of the global regulator Fis of the Sakai strain grown in the presence of cultured 
epithelial cells relative to incubation in the absence of epithelial cells was also investigated. 
Fis has been shown to act as a negative regulator of curli expression (52). As expected, the 
expression of the fis gene was determined to be down-regulated when growing in the 
presence of cultured epithelial cells. The transcription level of the biofilm-related genes 
csgA, csgD, Z3635 and cadA was also investigated for strain EDL933 in relation to strain 
Sakai, both incubated in the absence of epithelial cells where strain EDL933 forms biofilms 
and Sakai appears not to. The same pattern of transcription levels was found for EDL933: 
both curli genes (csgA and csgD) were up-regulated in relation to the Sakai strain, while 
Z3635, cadA and fis were down-regulated. These results suggest that during biofilm 
formation curli genes are up-regulated while Z3635, cadA and fis are down-regulated. We 
therefore infer that EDL933 strain appears to have the curli genes constitutively up-regulated 
while strain Sakai might only up-regulate them in the presence of epithelial cells. Other 
studies have found E. coli O157:H7 curli genes to be induced when in contact to HT-29 cells 
(29) HEp2 cells and cow colon explants (28, 52). Strains containing variations at the csgD 
promoter, which had induced expression of curli, are also associated with increased adhesion 
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to HEp2 cells (61). In agreement with our results, it has also been shown that curli genes are 
up-regulated in EDL933 when compared to the 86-24 strain (32). Curli expression is strain 
and condition specific, and its expression in E. coli and Salmonella spp. results in better 
adherence to eukaryotic cell lines than non-curliated strains (23). Curli have also been 
demonstrated to be essential for strong attachment to spinach leaves (35) and have also been 
implicated in the adherence to epithelial cells and pathogenesis of E. coli found in urinary 
tract infections (25). This suggests that curli not only plays an essential role in biofilm 
formation in abiotic surfaces but also actively participates in the adherence to epithelial cells. 
The fact that E. coli O157:H7 strain Sakai appears to up-regulate genes involved in curli 
expression suggests a linkage of these genes in biofilm formation as well as to adherence.  
The transcription of other biofilm related genes have been found to be enhanced when E. 
coli O157:H7 is grown in the presence of epithelial cells, such as wdP, Z1178, per, wbdQ, 
manC (21), dsbA, glpQ (29). Adhesion of E. coli O157:H7 has also been implicated to LPS 
biosynthesis (59) that is a major component of biofilm formation. E. coli O157:H7 probably 
has a large collection of factors that are expressed under specific environmental conditions, 
in response to different cues and many different pathways can be used as well as several 
regulatory mechanisms. It is also important to point out that key proteins might be modified 
in quality rather than quantity and might be regulated through phosphorylation, glycosylation 
or other post-transcriptional modifications that are not detected in expression analysis.  
Previous studies have shown that Shiga toxin producing E. coli, including the O157:H7 
serotype, persist in the ruminant gastrointestinal tract better than other E. coli pathotypes (6), 
it is therefore plausible that genes unique to the O157:H7 serotype that are involved in 
biofilm development may contribute to the persistence in specific situations such as those 
encountered in the bovine gastrointestinal tract. The ability of E. coli O157:H7 to induce 
biofilm formation under intestinal or extraintestinal environments suggests and adaptative 
advantage to survive in diverse niches. It remains a question if the development of biofilms 
in the intestinal tract in vivo is a prerequisite for infection and colonization.  
We have directly shown that biofilm formation contributes to adherence not only in 
strong biofilm forming strains but also in strains that lack in vitro biofilm forming activities. 
We determined that other strains (Sakai and 86-24) can produce biofilms in vitro and 
therefore have the ability to form biofilms in vivo as well. We also presented evidence that 
biofilm related genes found in EDL933 are also essential for cell adherence in Sakai and 86-
24 strains and that curli associated genes are differentially transcribed in the presence of 
cultured epithelial cells. Finally, we show that the level of biofilms in the three strains (Fig. 
1) and the level of adherence to epithelial cells (Figs. 2-5, Table 6) are directly correlated. As 
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biofilm concentration increases in strains Sakai and 86-24, their adherence to epithelial cells 
increases as well. In conclusion, we have offered evidence that the adherence of E. coli 
O157:H7 multiple strains to epithelial cells is strongly linked to biofilm formation and that at 
least the initial steps in biofilm formation play important roles in the cellular adherence of E. 
coli O157:H7 to the epithelium, providing valuable information on how this organism 
interacts with epithelial cells.  
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CHAPTER 4. RECOMMENDATIONS FOR FUTURE RESEARCH 
 
In this study we have shown that the adherence of E. coli O157:H7 to epithelial cells is 
strongly linked to biofilm formation not only in strong biofilm forming strains but also in 
strains that lack normal in vitro biofilm forming activities. Altough we determined that non-
biofilm forming strains (Sakai and 86-24) might be induced to produce biofilms in vitro, 
more studies are necessary to establish if other environmental conditions might induce 
stronger biofilms for these two strains. It is also recommended that other methods other than 
the crystal violet assay be used for establishing the presence of biofilms to confirm these 
results. 
We also presented evidence that biofilm related genes found in EDL933 are also essential 
for cell adherence in Sakai and 86-24 strains by showing that deletion mutants of biofilm-
related genes fail to adhere to both cell lines after 3 hours of infection. The tested genes are 
heterogenous in function and are involved in several different pathways; however no 
differences in adherence between the mutants were found. It is therefore recommended to 
further evaluate the behavior of these mutants for longer infection times to determine if the 
mutants might present differences in their adherence.   
Finally, we established that curli associated genes are differentially transcribed in the 
presence of cultured epithelial cells. However, the exact time point at which the up-
regulation of these genes occurs could be studied further by the use of a gene reporter assay 
that allows monitoring of the up-regulation of these genes as the bacteria interact with 
epithelial cells.  
We hypothesized that at least the initial steps in biofilm formation play important roles in 
the cellular adherence of E. coli O157:H7 to the intestinal epithelium of ruminants. It was 
thought that this contributed to its high persistence and intermittent shedding in cattle as well 
as playing a role in the cellular adherence to human intestines and contributing to its 
pathogenicity there. In earlier studies using in vitro tissue culture assays, Puttamreddy and 
Minion showed that biofilms were essential for adherence to cell surfaces (49). Also, the 
presence of biofilms has been established throughout the gastrointestinal tract in humans (36) 
lending further credence to the overall hypothesis. Further, anecdotal evidence from other 
studies also supports our hypothesis. The Cornick and Minion laboratories performed an in 
vivo genetic screen for persistence-negative mutants of strain 86-24 using a sheep model of 
colonization (Cornick et al. unpublished). This genetic screen used signature-tragged 
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mutagenesis, a powerful tool to screen large numbers of random-generated mutants in vivo 
for the inability to survive under different environmental conditions (19, 27). The idea was to 
identify genes essential to in vivo survival that were lost from a pool of mutants. Mutants 
could be individually identified through a molecular bar code sequence. Signature-tragged 
mutagenesis was adapted to a sheep model of persistence (ability to transiently colonize but 
not persist past 2-3 weeks). The sheep persistence model with strain 86-24 is well-developed 
and substitutes for a cattle colonization model (6). The screen was incomplete in that only 
1,326 random transposon mutants were screened of which 9 mutants were persistence-
negative after two in vivo screens with two sheep each. Two of those mutants were also 
defined by Puttamreddy and Minion as being biofilm-negative phenotype mutants in the 
EDL933 transposon library screen where 11,000 mutants were screened using an in vitro 
assay for biofilm formation (49).  
It seems reasonable to propose that additional deletion mutations be constructed in strain 
86-24 in biofilm-negative phenotype genes identified by Puttamreddy and Minion. These 
deletions could be constructed such that they also contain a molecular bar code sequence to 
monitor them in a host. A subsequent screen in sheep with a pool of these mutants with the 
appropriate controls would contribute important data to the testing of the hypothesis.  
If the hypothesis is proven correct by this set of experiments, then the next step would be 
to identify the environmental signal(s) in the gut that activates biofilm formation in Sakai and 
86-24 as well as identify potential mucosal surface differences between bovine and human 
epithelial cells.  
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APPENDIX A. BIOFILM ASSAY DATA 
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Corrected Average OD 595nm* p-value 
Strain T 24h 48h 72h 24h 48h 72h 
EDL933 
4°C 
-0.002±0.002 0.035±0.018 0.032±0.008 0.199 0.018 0.005 
86-24 -0.001±0.003 0.014±0.038 -0.00±0.002 0.333 0.276 0.218 
Sakai 0.003±0.001 -0.002±0.007 0.007±0.002 0.058 0.374 0.108 
EDL933 
RT 
0.412±0.065 0.531±0.005 0.548±0.031 <0.001 <0.001 <0.001 
86-24 0.029±0.020 0.053±0.010 0.012±0.011 0.049 0.004 0.073 
Sakai 0.039±0.020 0.108±0.003 0.023±0.040 0.023 0.017 0.012 
EDL933 
30°C 
0.403±0.055 0.319±0.114 0.432±0.042 <0.001 0.001 <0.001 
86-24 0.037±0.022 0.030±0.025 0.024±0.005 0.027 0.083 0.060 
Sakai 0.058±0.009 0.049±0.026 0.047±0.007 <0.001 0.029 0.185 
EDL933 
37°C 
0.461±0.118 0.443±0.086 0.374±0.032 0.001 <0.001 <0.001 
86-24 -0.001±0.020 0.039±0.030 -0.001±0.002 N/A 0.060 N/A 
Sakai -0.015±0.005 0.009±0.007 0.005±0.004 N/A 0.185 0.376 
* Data represents mean ± standard error of the mean of experimental minus blank; RT = 
room temperature. 
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APPENDIX B. MICROSCOPIC ADHESION ASSAY FIGURES 
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Sakai  !ecpD Sakai  !relA 
Sakai  !yaiH Sakai  !exhD 
86-24  !csgA 86-24  !ecpD 
86-24  !exhD 86-24  !yaiH 
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86-24  !csgA 86-24  !ecpD 
86-24  !exhD 86-24  !yaiH 
Sakai  !ecpD Sakai  !exhD 
Sakai  !yaiH Sakai  !relA 
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APPENDIX C. REAL-TIME RT-PCR DATA 
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Gene    Ct gene Ct Ref 
csgA 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 20.35 17.3 
Dilution 2 21.86 18.29 
Dilution 3 23.32 19.98 
Biological Rep 2 
Dilution 1 20.72 16.98 
Dilution 2 22.05 18.89 
Dilution 3 23.55 19.88 
Biological Rep 3 
Dilution 1 20.74 17.04 
Dilution 2 22.32 18.26 
Dilution 3 23.95 19.75 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 21.71 17.24 
Dilution 2 24.44 18.72 
Dilution 3 22.66 19.81 
Biological Rep 2 
Dilution 1 19.93 16.84 
Dilution 2 21.66 17.98 
Dilution 3 22.73 19.83 
Biological Rep 3 
Dilution 1 20.75 16.92 
Dilution 2 22.6 18.17 
Dilution 3 24.13 19.87 
csgD 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 11.28 16.56 
Dilution 2 12.59 17.19 
Dilution 3 13.34 18.54 
Biological Rep 2 
Dilution 1 12.54 16.34 
Dilution 2 13.81 17.22 
Dilution 3 14.5 18.65 
Biological Rep 3 
Dilution 1 12.57 16.45 
Dilution 2 13.82 17.14 
Dilution 3 14.33 18.75 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 12.28 16.84 
Dilution 2 14.41 17.82 
Dilution 3 15.83 19.77 
Biological Rep 2 
Dilution 1 13.68 16.8 
Dilution 2 15.19 18.3 
Dilution 3 16.02 19.84 
Biological Rep 3 
Dilution 1 12.92 16.54 
Dilution 2 14.42 18.05 
Dilution 3 16.07 20.45 
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Gene    Ct gene Ct Ref 
Z3635 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 16.95 15.93 
Dilution 2 18.15 17.01 
Dilution 3 20.33 18.63 
Biological Rep 2 
Dilution 1 16.85 15.31 
Dilution 2 17.95 17.62 
Dilution 3 20.2 18.4 
Biological Rep 3 
Dilution 1 16.18 15.3 
Dilution 2 17.91 17.18 
Dilution 3 12.15 18.66 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 15.22 15.72 
Dilution 2 16.78 17.07 
Dilution 3 18 18.46 
Biological Rep 2 
Dilution 1 15.07 15.35 
Dilution 2 15.78 16.97 
Dilution 3 18.17 18.68 
Biological Rep 3 
Dilution 1 15.05 15.77 
Dilution 2 15.79 17.2 
Dilution 3 18.19 18.68 
fis 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 25.11 15.56 
Dilution 2 25.47 17.19 
Dilution 3 25.83 18.54 
Biological Rep 2 
Dilution 1 23.42 15.34 
Dilution 2 24.63 17.22 
Dilution 3 26.49 18.65 
Biological Rep 3 
Dilution 1 24.03 15.45 
Dilution 2 24.78 17.14 
Dilution 3 26.76 18.75 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 24.39 15.84 
Dilution 2 24.83 17.28 
Dilution 3 25.95 18.77 
Biological Rep 2 
Dilution 1 23.73 15.8 
Dilution 2 24.36 17.3 
Dilution 3 25.42 18.84 
Biological Rep 3 
Dilution 1 22.75 15.54 
Dilution 2 24.5 17.05 
Dilution 3 25.6 18.45 
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Gene    Ct gene Ct Ref 
cadA 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 17.54 17.23 
Dilution 2 18.91 18.44 
Dilution 3 19.58 19.86 
Biological Rep 2 
Dilution 1 17.49 17.04 
Dilution 2 18.7 18.66 
Dilution 3 18.99 19.8 
Biological Rep 3 
Dilution 1 17.82 16.8 
Dilution 2 18.77 18.15 
Dilution 3 18.99 19.76 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 15.92 17.48 
Dilution 2 17.14 18.45 
Dilution 3 19.11 20 
Biological Rep 2 
Dilution 1 15.72 17.2 
Dilution 2 16.9 18.73 
Dilution 3 19.07 19.94 
Biological Rep 3 
Dilution 1 15.59 17.17 
Dilution 2 17.05 18.44 
Dilution 3 18.66 18.46 
Z1787 
In presence of 
HEp2 
Biological Rep 1 
Dilution 1 24.15 17.23 
Dilution 2 25.09 18.44 
Dilution 3 26.52 19.86 
Biological Rep 2 
Dilution 1 25.49 17.04 
Dilution 2 26.16 18.66 
Dilution 3 27.25 19.8 
Biological Rep 3 
Dilution 1 25.25 16.8 
Dilution 2 25.61 18.15 
Dilution 3 26.65 19.76 
In absence of 
HEp2 
Biological Rep 1 
Dilution 1 25.42 17.48 
Dilution 2 25.84 18.45 
Dilution 3 27.19 20 
Biological Rep 2 
Dilution 1 25.27 17.2 
Dilution 2 26.41 18.73 
Dilution 3 27.47 19.94 
Biological Rep 3 
Dilution 1 25.52 17.17 
Dilution 2 26.08 18.44 
Dilution 3 27.33 18.46 
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